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A B S T R A C T
Background
The burden of cardiovascular disease world-wide is one of great concern to patients and health care agencies alike. Cardiac rehabilitation
aims to restore patients with heart disease to health through exercise only based rehabilitation or comprehensive cardiac rehabilitation.
Objectives
To determine the effectiveness of exercise only or exercise as part of a comprehensive cardiac rehabilitation programme on the mortality,
morbidity, health-related quality of life (HRQoL) and modifiable cardiac risk factors of patients with coronary heart disease.
Search strategy
Electronic databases were searched for randomised controlled trials, using standardised trial filters, from the earliest date available to
December 31st 1998.
Selection criteria
Men and women of all ages, in hospital or community settings, who have had myocardial infarction, coronary artery bypass graft or
percutaneous transluminal coronary angioplasty, or who have angina pectoris or coronary artery disease defined by angiography.
Data collection and analysis
Studies were selected independently by two reviewers, and data extracted independently. Authors were contacted where possible to
obtain missing information.
Main results
This systematic review has allowed analysis of an increased number of patients from approximately 4500 in earlier meta-analyses to
8440 (7683 contributing to the total mortality outcome).
The pooled effect estimate for total mortality for the exercise only intervention shows a 27% reduction in all cause mortality (random
effects model OR 0.73 95% confidence interval 0.54 to 0.98). Comprehensive cardiac rehabilitation reduced all cause mortality, but
to a lesser degree (OR 0.87 95% confidence interval 0.71 to 1.05). Total cardiac mortality was reduced by 31% (random effects model
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OR 0.69 95% confidence interval 0.51 to 0.94) and 26% (random effects model OR 0.74 95% confidence interval 0.57 to 0.96) in
the exercise only and comprehensive cardiac rehabilitation groups respectively. We found no evidence of an effect of the interventions
on the occurrence of non-fatal myocardial infarction. There was a significant net reduction in total cholesterol (pooled WMD random
effects model -0.57 mmol/l 95% confidence interval -0.83 to -0.31) and LDL (pooled WMD random effects model -0.51 mmol/l
95% confidence interval-0.82 -0.19) in the comprehensive cardiac rehabilitation group.
Authors’ conclusions
Exercise-based cardiac rehabilitation is effective in reducing cardiac deaths. It is not clear from this review whether exercise only or a
comprehensive cardiac rehabilitation intervention is more beneficial. The population studied in this review is still predominantly male,
middle aged and low risk. Identification of the ethnic origin of the participants was seldom reported. It is possible that patients who
would have benefited most from the intervention were excluded from the trials on the grounds of age, sex or co-morbidity.
P L A I N L A N G U A G E S U M M A R Y
Regular exercise or exercise with education and psychological support can reduce the likelihood of dying from heart disease
Coronary heart disease (CHD) is one of the most common forms of heart disease. It affects the heart by restricting or blocking the
flow of blood around it. This can lead to a feeling of tightness in the chest (angina) or a heart attack. Cardiac rehabilitation aims to
restore people with CHD to health through regular exercise or a combination of exercise with education and psychological support.
The findings of this review indicate that either form of cardiac rehabilitation can reduce the likelihood of dying from heart disease.
More research is needed.
B A C K G R O U N D
The burden of cardiovascular disease (CVD) world-wide is one
of great concern to patients and health care agencies alike. Circu-
latory diseases, including myocardial infarction (MI) and stroke,
kill more people than any other disease. This accounts for 15 mil-
lion deaths, 30% of the annual total, every year. (WHO 1997).
In the USA more than 13.5 million Americans have a history of
MI, or experience angina pectoris (Wenger 1995). In Australia in
1994, cardiovascular disease (the largest component of which is
coronary heart disease (CHD)), was certified as the primary cause
in 43.33% of all deaths in Australia (Goble&Worcester 99). East-
ern Europe is now experiencing an increasing number of deaths
from CVD, across all socio-economic groups, death rates exceed-
ing those inWestern Europe, theUSA,Australia andNewZealand
(WHO 1994). Asia too is suffering an increasing prevalence of
CVD, particularly among the growing professional, managerial,
business and factory supervising groups (Janus 1996).
CHD is the single leading cause of death for both men and women
in the UK, accounting for 238 deaths per 100,000 population
in 1997 (approximately 140,000 people) (OHE 1999). Scotland,
Northern Ireland and England andWales rank 3rd, 5th and 9th in
the top ten of 30 selectedOrganisation for Economic Cooperation
and Development (OECD) countries with CHD rates (in men
and women aged 45-64) some four or five times those of the
countries at the bottom of the list (OHE 1999). Diseases of the
circulatory system accounted for 108.2 million days of certified
incapacity inmen and women in 1996/97, 12% of the total (OHE
1999). In the older age group (over 65) one fifth of men and one
eighth of women in England and Wales were treated for CHD
in General Practice in 1996 (ONS 1999). These observations are
likely to hold true for the population of other developed countries.
Cardiac rehabilitation services have been defined as:
“comprehensive, long-term programmes involving medical evalu-
ation, prescribed exercise, cardiac risk factor modification, educa-
tion and counselling for patients who have suffered a myocardial
infarction (MI), undergone cardiac surgery or suffer from heart
failure or angina pectoris ” (Wenger 1995).
Goble & Worcester (Goble & Worcester 99) have taken previ-
ous definitions by the World Health Organisation (WHO), the
United States Public Health Service and the Cardiac Rehabilita-
tion Working Group of the European Society of Cardiology and
give a broader definition of cardiac rehabilitation;
“Cardiac rehabilitation is the co-ordinated sum of interventions
required to ensure the best physical, psychological and social con-
ditions so that patients with chronic or post-acute cardiovascu-
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lar disease may, by their own efforts, preserve or resume optimal
functioning in society and, through improved health behaviours,
slow or reverse progression of disease.”
Current provision of cardiac rehabilitation in the UK varies
widely in practice and organisation (Davidson 1995). There
is evidence that national guidelines for cardiac rehabilitation
(Thompson 1996) and secondary prevention measures (ASPIRE
1996, Campbell 1998) are under applied (NHS 1998, Stokes
1998). The National Service Framework for CHD (Department
of Health DOH 2000) has been published to address some of
these issues.
Systematic reviews and meta-analyses of cardiac rehabilitation
Data from two published and widely cited meta-analyses (
Oldridge 1988, O’Connor 1989) of over 4,000 patients have
demonstrated that patients randomised to exercise-based cardiac
rehabilitation after MI have a statistically significant reduction in
all-cause and cardiac mortality of about 20 to 25% compared to
patients receiving conventional care. No significant effect on non-
fatal re-infarctions was found. Reviews of cardiac rehabilitation
(May 1982, Oldridge 1988, O’Connor 1989, Lau 1992, West
1995, Ebrahim 1996) have varied considerably in the trials they
included and excluded, indicating the difficulty in defining precise
criteria.
The USA (Wenger 1995), Australia (Goble & Worcester 99) and
the UK (NHS 1998) have published comprehensive analyses of
the systematic reviews available to date to give the professions up
to date information on which to base decisions. Two hundred and
fifteen systematic reviews were identified by the NHS Centre for
Reviews and Dissemination (NHS 1998) in the Health Care Bul-
letin on Cardiac Rehabilitation, of which seven were considered
in detail (Oldridge 1988, Bobbio 1989, O’Connor 1989, Duryee
1992, Hill 1992, Bucher 1994, Wenger 1995). This bulletin con-
cluded “exercise improves physical aspects of recovery at no addi-
tional risk, but as a sole intervention it is not sufficient to reduce
risk factors, morbidity or mortality.” This is at odds with the find-
ings of the Oldridge (Oldridge 1988) and O’Connor (O’Connor
1989) reviews which suggested that there was no difference in the
effects seen with exercise alone or in combination with other in-
terventions.
However, commentators have raised a number of concerns regard-
ing these reviews (Ebrahim 1996, West 1995, NHS 1998, Goble
&Worcester 99). The trials included were small and often of poor
methodological quality. Incomplete literature reviewmethodsmay
have resulted in publication bias thereby resulting in an over-es-
timate of the benefit of cardiac rehabilitation. The randomised
controlled trials (RCTs) used in the reviews have focused almost
exclusively on low-risk, middle-aged males post MI, thereby ex-
cluding women, elderly people, and other cardiac patient groups
such as cardiac surgery patients or heart failure patients who may
benefit more in absolute terms. These caveats apply to most of the
trials on which all systematic reviews have been based.
Finally, the meta-analyses have reported evidence of statistical het-
erogeneity thereby putting in question the use of statistical pool-
ing. Both Oldridge (Oldridge 1988) and O’Connor (O’Connor
1989) address the effect heterogeneity may have had on their re-
sults accepting that time to randomisation, type of intervention
and length of follow-up may have had some effect on their meta-
analyses. The NHS Centre for Reviews and Dissemination (NHS
1998) acknowledges that the evaluation of the cardiac rehabilita-
tion literature is very difficult due to the variability of the inter-
ventions and patient populations studied.
Given the existence of new evidence, a current review of the effec-
tiveness of cardiac rehabilitation is indicated. Given its breadth,
it is proposed that cardiac rehabilitation be grouped into three
separate interventions: (1) exercise-based interventions; (2) edu-
cational interventions; and (3) psycho-social interventions. This
review will focus on exercise-based interventions for CHD and
other Cochrane reviews will focus on the other areas.
O B J E C T I V E S
To determine the effectiveness of exercise-based interventions
compared with usual care on the mortality, morbidity, health-re-
lated quality of life (HRQoL) and modifiable cardiac risk factors
of patients with coronary heart disease (CHD).
M E T H O D S
Criteria for considering studies for this review
Types of studies
All English and non-English randomised controlled trials (RCTs)
of exercise-based cardiac rehabilitation versus conventional care
with a followup period of greater than 6months have been sought.
Types of participants
Men and women of all ages, in both hospital-based and com-
munity-based settings, who have had myocardial infarction (MI),
coronary artery bypass graft (CABG) or percutaneous translumi-
nal coronary angioplasty (PTCA), or who have angina pectoris
or coronary artery disease defined by angiography have been in-
cluded. These different patient types were grouped together. Stud-
ies involving participants following heart transplant, heart valve
surgery or heart failure have been excluded.
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Types of interventions
Cardiac rehabilitation is defined for this review as inpatient, outpa-
tient or community-based intervention that is applied to a cardiac
patient population. The intervention must include some form of
exercise training.
The following comparisons have been made:
1) Exercise training alone and usual care vs. usual care alone (ex-
ercise only vs. usual care).
2) Exercise training in addition to psychosocial and/or educational
interventions vs. usual care alone (comprehensive cardiac rehabil-
itation vs. usual care).
Types of outcome measures
The principal outcome measures were:
1 All cause mortality
2 Cardiac mortality, further subdivided into deaths fromMI, sud-
den cardiac deaths, deaths from cerebrovascular disease (CVD)
3 Non fatal MI
4 Revascularization, CABG, PTCA
5 Non fatal CVD events
6 Health related quality of life (HRQoL)
Secondary outcome measures:
Modifiable cardiac risk factors:
1 Smoking behaviour
2 Blood pressure
3 Blood lipid levels
Search methods for identification of studies
Electronic databases were searched from the earliest date available
to December 31st 1998.
The search strategy below was used to identify RCTs of exer-
cise based cardiac rehabilitation using the following electronic
databases: Cardiovascular randomised controlled trials register
at McMaster University, Central/CCTR, MEDLINE, EMBASE,
CINAHL, AMED, BIDS ISI, and SPORTSDISCUS (using ap-
propriate RCT filters for MEDLINE and EMBASE, Dickersin
1994, Lefebvre 1996). In addition, reference lists of retrieved arti-
cles have been examined for further trials, conference proceedings
have been examined for unpublished and ongoing trials of cardiac
rehabilitation, and expert advice has been sought.
Search Strategy
MYOCARDIAL-ISCHEMIA*:ME
CORONARY-ARTERY-BYPASS*:ME
(ISCHEMI* near HEART)
(ISCHAEMI* near HEART)
(CORONARY near DISEASE*)
(CORONARY near BYPASS)
(CORONARY near THROMBO*)
(CORONARY near ANGIOPLAST)
(CORONARY near ANGIOPLAST*)
(MYOCARD* near ISCHEMI*)
(MYOCARD* near ISCHAEMI*)
(MYOCARD* near INFARCT*)
(HEART near INFARCT*)
ANGINA
(((((((#1 or #2) or #3) or #4) or #5) or #6) or #7) or #8)
(((((#9 or #10) or #11) or #12) or #13) or #14)
(#15 or #16)
REHABILITATION*:ME
EXERCISE*:ME
EXERCISE-THERAPY*:ME
SPORTS*:ME
PHYSICAL-EDUCATION-AND-TRAINING*:ME
EXERTION*:ME
REHABILITAT*
(PHYSICAL* near FIT)
(PHYSICAL* near FITNESS)
(PHYSICAL* near TRAIN*)
(PHYSICAL* near ACTIVIT*)
(TRAIN* near STRENGTH*)
(TRAIN* near AEROBIC*)
(AEROBIC* near EXERCISE*)
KINESIOTHERAP*
(EXERCISE* near TRAIN*)
(((((((#18 or #19) or #20) or #21) or #22) or #23) or #24) or #
25)
(((((((#26 or #27) or #28) or #29) or #30) or #31) or #32) or #
33)
(#34 or #35)
(#17 and #36)
Data collection and analysis
Over 4000 citations were retrieved from the search of databases.
The titles and abstracts of these were examined by two reviewers,
and 300 references were retrieved for possible inclusion. Two re-
viewers (JJ & RT or KR) then independently selected trials to be
included in this review, by the use of a 6-question inclusion/exclu-
sion form. In all cases disagreements about any study inclusions
have been resolved by consensus among the authors and a third
reviewer (DT) was consulted if disagreement persisted.
Once studies had been formally included in the review, data was
extracted independently by two reviewers (KR, JJ), and chief in-
vestigators were contacted where necessary to provide additional
information. In addition to study outcome data, the quality of
trials was assessed independently in terms of concealment of al-
location, losses to follow up and blind assessment of outcomes.
Data concerning patient characteristics; age, sex, type of CHD,
chronic or acute condition, and details of the intervention, its du-
ration and intensity, and length of follow up, were also collected
as stated a priori to perform stratified analysis of the data using
meta-regression.
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Dichotomous outcomes for each study have been expressed as odds
ratios and 95% confidence intervals (CI). Continuous variables
have been expressed as themean change frombaseline to followup,
and the standard deviation difference from baseline to follow up
for each comparison group. Where standard deviation differences
have not been reported in the source papers, allowance has been
made for within patient correlation from baseline to follow up
measurements by using the correlation coefficient between the
two (see Cochrane Heart Group website for details and, Follman
1992). A weighted mean difference (WMD) and 95% CI have
been calculated for each study. Data from each study were pooled
as appropriate using a fixed effect model, except where substantial
heterogeneity existed according to the Z statistic, and a random
effects model was used (where a random effects model was used
this is indicated in parentheses).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Details of the studies included in the review are shown in the table
of characteristics of included studies.
Several studies that had been included in previous meta-analyses
(Oldridge 1988, O’Connor 1989) have not been included in this
review (see table 1 for studies excluded from the current analyses
and reasons).
Risk of bias in included studies
See tables 2 and 3, and also results section and discussion.
The quality of reporting in general was poor with only a few au-
thors describing themethod of randomisation or confirming blind
assessment of outcomes. Losses to follow up were relatively high
across trials as has been reported elsewhere in the cardiac rehabil-
itation literature (O’Connor 1989), but reasons for dropout were
often not reported. Several trials have excluded significant num-
bers of patients post randomisation, and thus in an intention to
treat analysis, these then have been regarded as dropouts. Blinding
of intervention allocation is not possible in rehabilitation inter-
ventions and this raises the possibility of bias. Lack of blinding of
patients or investigators will however have little effect onmortality
outcome data.
Effects of interventions
A total of 36 trials of exercise based cardiac rehabilitation were
found. Four were excluded (see table of excluded studies). Of
the 32 included trials, several were further subdivided into seper-
ate studies on the basis of different intervention and comparison
groups (WHO 83, Millar/Debusk 84, Sivarajan 82 and Carlsson
98). Thus the number of seperate studies totals 51. Not all studies
measured all outcomes of interest.
Clinical Events
The pooled effect estimate for total mortality for the exercise only
intervention showed a 27% reduction in all cause mortality (ran-
dom effects model OR 0.73 (0.54, 0.98)). Similarly, comprehen-
sive cardiac rehabilitation reduced all cause mortality compared to
usual care, but to a lesser, and non-significant, degree (13% OR
0.87 (0.71, 1.05)).
Total cardiacmortalitywas reducedby 31%(random effectsmodel
OR 0.69 (0.51, 0.94)) and 26% (random effects model OR 0.74
(0.57, 0.96)) in the exercise only and comprehensive cardiac re-
habilitation intervention groups respectively when compared to
usual care.When subdividing cardiac deaths into those from coro-
nary heart disease, the reduction in mortality is greater at 35%
and 28% respectively for exercise only and comprehensive cardiac
rehabilitation versus usual care. No significant effect was seen with
either intervention on sudden cardiac deaths. However, only 4 ex-
ercise only intervention trials and 14 trials (of which 12 formed
part of the WHO study) in the comprehensive cardiac rehabilita-
tion group reported this as an outcome. CVD mortality was re-
ported in only 1 trial in the exercise only group (NEHDP) where
the intervention showed a reduction in CVDmortality (OR 0.45
(0.18, 1.08)), and in the 12WHO trials of comprehensive cardiac
rehabilitation the pooled effect estimate was 0.83 (0.61, 1.13).
Neither exercise only rehabilitation or comprehensive cardiac re-
habilitation had any effect on recurrence of non-fatal MI, with
pooled effect estimates of 0.96 (0.69, 1.35) and 0.88 (0.7, 1.12)
respectively.
Only 5 trials reported CABG as an outcome measure in the exer-
cise only group. The results from individual trials showed hetero-
geneity between studies, and no overall benefit on revasculariza-
tion rates. In the comprehensive cardiac rehabilitation interven-
tion group, the pooled effect estimate for 10 trials was 0.83 (0.6,
1.13). Similarly, there is little data for PTCA, with only 1 trial re-
porting this as an outcome in the exercise only group, and showing
no effect of the intervention (Speccia 96). In the comprehensive
cardiac rehabilitation group, there was considerable heterogeneity
between studies.
Using a combined outcome of mortality, non-fatal MIs and revas-
cularisations (CABG and PTCA), a pooled effect estimate of 0.81
(0.65, 1.01) for the exercise only rehabilitation group, and 0.81
(0.69, 0.96 random effectsmodel) for comprehensive cardiac reha-
bilitation was found. Thus, cardiac rehabilitation, either exercise
alone or comprehensive cardiac rehabilitation, results in a 20%
reduction in pooled “adverse” clinical outcomes.
Modifiable risk factors
Lipids
Total blood cholesterol wasmeasured in 3 trials in the exercise only
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group (approximately 120 patients in each comparison group)
and in 9 trials in the comprehensive cardiac rehabilitation group
(600 patients in each group). There was a significant net reduction
in total cholesterol in the comprehensive cardiac rehabilitation
group (pooled WMD random effects model -0.57 mmol/l (-0.83,
-0.31)), but not the exercise only group (pooled WMD -0.03
mmol/l (-0.27, 0.22)). Neither intervention had any significant
effect on HDL cholesterol.
LDL cholesterol was measured in 2 small trials in the exercise only
group (50 patients in each comparison group), and in 6 trials in
the comprehensive cardiac rehabilitation group (360 patients in
each group). LDL was significantly reduced in the comprehensive
cardiac rehabilitation group (pooledWMD random effects model
-0.51 mmol/l (-0.82, -0.19)), with no significant effect of inter-
vention in the exercise only rehabilitation group.
Triglycerides were measured in 3 trials in the exercise only group,
with approximately 120 patients in the comparison groups. There
was significant heterogeneity between trials, with 1 trial showing
favourable effects of exercise on triglyceride levels, and 2 trials (in-
cluding one larger study) showing no effect. In the comprehensive
cardiac rehabilitation group, triglycerides were measured in 5 trials
with 400 patients in the comparison groups. There was a small but
significant reduction in triglycerides in the comprehensive cardiac
rehabilitation group (pooled WMD random effects model -0.29
(-0.42, -0.15)).
Only one trial reported concomitant use of cholesterol-lowering
drugswhich increased over the durationof the trial, suggesting that
some or all the reduction in blood cholesterol could be attributed
to pharmacological treatment (Carlsson 98CABG). In other trials,
this remains a possible explanation but no data were reported.
Blood pressure
Only one trial reports blood pressure as an outcome in the exercise
only group where no effect was seen (n=70 in each comparison
group). Four trials reported blood pressure changes in the compre-
hensive cardiac rehabilitation group. There was significant hetero-
geneity in systolic blood pressure between trials. Two larger trials
(WHO Helsinki, SCRIP) showed favourable effects of compre-
hensive cardiac rehabilitation, with reductions in SBP of -9mmHg
(-13.6, -4.4), and -6.4mmHg (-6.4, -0.99) respectively. DBP was
significantly reduced in the comprehensive cardiac rehabilitation
group (pooled WMD random effects model -2.24 mmHg (-3.63,
-0.85)). It should be noted that in two trials BP rose in both in-
tervention and control groups, but as BP tended to rise more in
the control groups, net changes were negative.
Smoking
There was no overall effect of rehabilitation on smoking status in
the exercise only group in the 3 trials where smoking was reported
as an outcome. In the 5 trials reporting smoking in the com-
prehensive cardiac rehabilitation group, the larger trials showed
favourable but non-significant effects of the intervention (pooled
effect estimate OR 0.78 (0.55, 1.11)).
Health related quality of life
Health related quality of life (HRQoL) was reported in 11 trials
overall. Description of these studies, HRQoL outcomes, results
and comments are presented in tables 4 and 5. Eighteen different
instruments were used to assess HRQoL, 4 studies used unvali-
dated self report measures, 2 used the Beck Depression Inventory,
and 2 used the Quality of Life after Acute Myocardial Infarction
Questionnaire (QoLAMI Guyatt 1986). For these reasons, and
the relatively small number of trials reporting HRQoL as an out-
come, it was not possible to combine data in a quantitative way,
and so these data are presented qualitatively. In the exercise only
group, in 4 trials, overall small changes or no change in various
HRQoL measures were found. In the comprehensive cardiac reha-
bilitation group, 7 trials reportedHRQoLoutcomes.Most of these
studies show small and variable effects in a number of HRQoL
measures. One trial shows significant improvements with the in-
tervention, showing reductions in anxiety and depression (Lewin
92). Oldridge (Oldridge 91) showed substantial and significant
improvement in both rehabilitation and control groups over 12
months, although there was no significant difference between the
two groups. Significant improvement in both intervention and
control groups highlights the importance of recognising the nat-
ural course of recovery after MI.
Quality of trials
Individual studies fromboth groups of interventions were grouped
into a number of categories based on quality criteria. Sixteen per-
cent of all studies reported a clear description of an adequate
methodof randomisation, 2%reported a clear descriptionof an in-
adequate method of randomisation, and in the remainder (82%),
reports were unclear. Blind assessment of outcomes was reported
in only 8% studies. Using a 20% loss to follow up as a cut off,
71% of studies reported a less than 20% loss to follow up, and the
remainder (29%) a greater than 20% loss to follow up.
As the reporting of quality criteria in the published papers was
so poor, we attempted to contact all authors for clarification of
the method of concealment allocation, the number of patients
lost to follow up, and whether outcome assessors were blind to
group allocation. The method used by the authors to randomise
patients in the primary studies was determined by giving a number
of options to choose from thereby not suggesting one method was
preferable to another. Seventy two percent of authors were located,
of these 50% responded. The effect of the quality of studies on
the pooled effect estimate has been examined using total mortality
as the outcome measure for any exercise intervention. Following
attempts to clarify the method of allocation concealment, 12/41
(29%) studies reporting total mortality as an outcome used an
adequate method of randomisation, 2/41 (5%) studies used an
inadequate method, and in the remainder (27 studies, 66%) the
method was unclear. The pooled effect estimate for those studies
with an adequate method of randomisation was OR 0.78 (0.61,
0.99 random effects model), for those with an inadequate method
of randomisation OR 0.53 (0.2, 1.4), and for those where the
method remains unclear OR 0.88 (0.7, 1.1). Twenty seven studies
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(66%) reporting total mortality as an outcome measure and had
less than 20% loss to follow up. For these studies the pooled effect
estimate was 0.84 (0.69, 1.0). For the 14 remaining studies (34%)
with greater than 20% loss to follow up, the pooled effect estimate
was 0.8 (0.57, 1.14 random effects model). Following contact
with the authors, 9/41 (22%) studies reported blind assessment
of outcomes, where the pooled effect estimate for total mortality
was OR 0.78 (0.54, 1.12), and in 32 studies (78%) this remains
unclear (OR 0.84 (0.7, 0.97) random effects model).
The pooled effect estimate for total mortality, any exercise inter-
vention was OR 0.83 (0.69, 0.96 random effects model). Exclud-
ing the 2 studies with inadequate randomisation had little effect
on the summary estimate (OR 0.83 (0.7, 0.98 random effects
model).
Evidence of publication bias using total mortality as an outcome
for any intervention was examined both visually in the form of a
funnel plot, and statistically (Egger 1997). There was no evidence
of significant publication bias either visually or statistically (Egger
test p=0.319).
D I S C U S S I O N
In contrast to previous reviews, the current systematic review has
allowed analysis of an increased number of patients from ap-
proximately 4500 in the earlier meta-analyses (Oldridge 1988,
O’Connor 1989) to 8440 (2845 in exercise only and 5595 in the
multiple rehabilitation group), with 7683 patients contributing
to the total mortality outcome. Twenty-seven further RCTs have
been included, most published since the original meta-analyses in
the late 1980s. Both a more comprehensive search strategy and
the passage of time have allowed the introduction of more trials
and patients.
This review, in contrast to previous reviews and the NHS Centre
for Reviews & Dissemination bulletin, demonstrates a 27% re-
duction in total mortality in patients who have undergone exer-
cise only based cardiac rehabilitation, and a 13% reduction in to-
tal mortality in those who have undergone comprehensive cardiac
rehabilitation. Somewhat better outcomes were also achieved for
cardiac deaths in those receiving exercise-only rehabilitation than
comprehensive rehabilitation. However, there is insufficient data
to determine whether exercise only rehabilitation is significantly
better than comprehensive rehabilitation.
Trial quality
Unlike previous reviews, we have attempted to examine the qual-
ity of the trials included. It is clear that the majority of trials were
under-powered. The reporting of quality issues in the primary
studies was generally poor. For most of the trials the method of
randomisation was not reported clearly, and only 4 trials reported
blind assessment of outcomes. Approximately one third of trials
reported a greater than 20% loss to follow up. Authors of the pri-
mary studies were contacted where possible to clarify methods of
randomisation, losses to follow up and blinding. Stratified analysis
using the additional information provided by authors had little
effect on the pooled effect estimate for total mortality for all trials
with any exercise intervention. For those trials where the method
of randomisation was clear and adequate, the pooled effects esti-
mate was OR 0.78 (0.61, 0.99 random effects model). We found
no evidence of publication bias.
Role of drug treatments
The reasons for the differences between exercise only rehabilitation
and comprehensive cardiac rehabilitation are unclear. Differences
may be due to different medications taken during the trial period.
These are generally not well reported, but are in part dependent
on when the trials were carried out and hence what medication
was prescribed. There are only five new trials in the exercise only
analysis, the latest of these was published in 1999 (although the
results pertain to patients from the late 1980s). None appeared
to be receiving statins (although details were not always given),
under 50% (approximately) were on beta-blockers (where stated)
and there was no record of whether thrombolysis was given on
admission. There are 15 new trials included in the comprehen-
sive cardiac rehabilitation intervention analysis, eight published
since 1995 and the latest being published in 1999. Again there
are few details of medication or thrombolysis, although more pa-
tients seem to be prescribed statins or beta-blockers. There is only
one study that details thrombolytic treatment (Carlsson 97). In
another study (Carlsson 98 AMI) the proportion of participants
receiving statins in the intervention group rose from 2.6% at the
start of the trial to 75% at the one year follow up. Use of aspirin
was detailed in Worsrnu, Bell and Schuler/Niebauer (Worsornu
96, Bell 99, Schuler/Niebauer) but was not mentioned in other
trial reports. The incremental benefit of cardiac rehabilitation on
mortality in a world where the majority of patients will receive
thrombolysis, aspirin, statins and increasingly ACE inhibitors has
not been studied adequately.
Non-fatal myocardial infarction
Both exercise only interventions and comprehensive cardiac reha-
bilitation have no effect on the recurrence of non-fatal MI. This
confirms the findings of Oldridge and O’Connor. It is unclear
why there is a decrease in the mortality rate after cardiac rehabil-
itation but not in the rate of non-fatal reinfarction. It has been
suggested that either there is a true increase in the frequency of
non-fatal MI after rehabilitation, or there may be increased sur-
vival after MI with rehabilitation. The mechanism for reduced
mortality in patients who have received rehabilitation is not clear,
but may be due to improved myocardial revascularisation, protec-
tion against fatal dysrhythmias, improved cardiovascular risk fac-
tor profile, improved cardiovascular fitness, or increased patient
surveillance (Oldridge 1988). There is insufficient data in this re-
7Exercise-based rehabilitation for coronary heart disease (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
view to make any conclusions about the effect of cardiac rehabili-
tation on revascularization rates.
Reduction in blood cholesterol
With comprehensive cardiac rehabilitation there were significant
reductions in both total blood cholesterol and LDL cholesterol,
however, the effects of cholesterol-lowering drugs cannot be ex-
cluded. No effect of exercise only based rehabilitation was seen
for total or LDL cholesterol. There was no effect of rehabilitation
of either type on levels of HDL cholesterol, although small but
significant reductions in triglycerides occurred in the comprehen-
sive cardiac rehabilitation group. Very little data were collected on
blood pressure measurement. Similarly, the number of trials that
reported smoking as an outcome were small.
Health related quality of life
One of the primary objectives of this review was to contribute to
the evidence concerning HRQoL outcomes followingMI. The di-
versity of instruments used in assessing psychological andHRQoL
outcomes was surprising, as was the fact that four studies used un-
validated self-report instruments. The majority of measures that
were used were long, psychological questionnaires not particularly
suited for use in general practice, busy hospital departments or car-
diac rehabilitation programmes. Only four studies used a disease
specific questionnaire. With the advent of increasingly effective
medication for post MI patients, mortality and reinfarction may
not be the best method of measuring the effectiveness of cardiac
rehabilitation. HRQoL and psychological measures assess the pa-
tient’s performance in society and should be part of the standard
outcome measures for all cardiac patients.
Characteristics of trial participants
All the participants in these studies had a specific exercise interven-
tion with or without some formal education on lifestyle changes.
The question as to whether the exercise only participants received
ad hoc education while exercising or from other sources has not
been addressed. All participants in the included studies had doc-
umented CHD, the majority of the participants having suffered
an MI. Some participants had documented CHD having suffered
angina or undergone coronary angiography (Fletcher 94, Krachler
97, Lifestyle Heart, Schuler/Niebauer, SCRIP), while others had
undergone CABG (Carlsson 98 CABG, Engblom,Worsornu 96).
We have combined these different patient groups as there is in-
sufficient data at present to stratify trials by type of CHD. The
number of women participants (4.4% in exercise only and 11%
in comprehensive cardiac rehabilitation) was low and few studies
mentioned the ethnic origin of their participants. The mean age of
the participants was 53.1 (exercise only) and 56.3 (comprehensive
cardiac rehabilitation). Although most studies had an upper age
limit of at least 65 years of age, this is not reflected in the mean
age of the participants. The majority of the studies had exclu-
sion criteria that would have excluded those participants who had
co-morbidity, or heart failure. In some studies this may have ac-
counted for up to 60% of the patients considered for the trial, and
certainly the older patients would be more likely to be affected.
There would seem to be no biological reason why patients who
are older, female or from differing ethnic background should not
benefit from cardiac rehabilitation. Observational and non ran-
domised controlled trials have found benefits to older (Willmer
1999, Stahle 1999) and female (Cannistra 1992) patients.
Variation in rehabilitation interventions
The separate classification of trials into exercise only and compre-
hensive cardiac rehabilitation in the current systematic review was
implemented to try to reduce heterogeneity between the trials. In
any analysis of a complex, multidisciplinary intervention, hetero-
geneity between trials will inevitably pose a problem to interpret-
ing any overall effects. However within each of these groups there
are some variations in the time post event to randomisation, type
of participant or intervention and length of follow up. Within the
exercise only group of studies the point of randomisation varied
between the time of acute MI (Kentala 72, Sivarajan 82) to 6
weeks or 1 year after acute MI (Stern 83). In the comprehensive
cardiac rehabilitation group time of randomisation varied between
the time of acute MI (Bengtsson 83, Fridlund 91, Sivarajan 82) to
4 to 6 weeks post event (Oldridge 91, Vermuelen 83, PRECOR).
Duration of follow up again varied within each of the groups.
In the exercise only group follow up varied between 6 months
(Ballantyne 82, Sivarajan 82, Worsornu 96) to 5 years (Bethell 90,
Erdman 86, Wilhelmson 75). In the comprehensive cardiac reha-
bilitation group the follow up varied between 6 months (Fletcher
94, Miller/DeBusk 1A, Miller/DeBusk 1B, Miller/DeBusk 2A,
Miller/DeBusk 2B, Sivarajan 82) to 6 years (Schuler/Niebauer).
The benefits of cardiac rehabilitation reported in this systematic
review have accrued over an average of 2.4 years, and we cannot
extrapolate the benefits beyond the period of the trials. The ef-
fect of trial length on the benefit of cardiac rehabilitation in terms
of duration over which benefits are seen and maintained will be
addressed in an update of this review. The type of intervention
varied between gym based aerobic exercise twice a week for 4
weeks (Bertie 92) to a four stage intervention lasting 30 months
with inpatient stays (Engblom). Other interventions included be-
ing sent home with a tape and manual, supported by a facilitator
(Lewin 92), intensive dietary changes, stress management tech-
niques, and daily exercise and support groups (Lifestyle Heart),
or mail out packages on diet and exercise (Heller 93). Five trials
gave all participants some instruction and education prior to the
intervention (Carlsson 97, NEHDP, Schuler/Niebauer, Speccia
96, Wilhelmson 75). This varied between information on increas-
ing exercise levels and diet (Wilhelmson 75) to all participants
taking part in a low level exercise course for 6 weeks (NEHDP).
Given the differences in the trials, in the age, sex, and diagnosis
of the participants, type and length of intervention, the differing
length of follow up, and the quality of trials, it is our intention
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to perform stratified analyses using meta-regression techniques in
a subsequent update of this review to further explore differences
between the studies.
Long-term follow up
Three of the trials included in this meta-analysis have published
long term results of 15, 19 and 11 years respectively: WHO
Helsinki (Hamalainen 1995), NEHDP (Dorn 1999) and Bethell
1990 (Bethell 1999). The two trials of exercise only rehabilita-
tion (NEHDP, Bethell 90) found no effect for the intervention
on total mortality at 10 and 11 years respectively, or at 19 years
(NEHDP). Both studies noted that there were drop outs from
the original intervention group and “drop ins” from the control
groups (31% drop ins NEHDP, 25% drop ins Bethell). This and
the advent of improved drug intervention may have compromised
the treatment effect over time. The comprehensive cardiac rehabil-
itation trial (Hamalainen 1995) found a significantly lower inci-
dence of sudden death (16.5% vs. 28.9%, p=0.006) and coronary
mortality (47.9% vs. 58.5%, p =0.04) in the intervention group
compared with controls. It has been suggested that the addition
of educational and counselling programmes may have contributed
to the study group differences in survival in the Hamalainen study
(Dorn 1999).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Exercise-based cardiac rehabilitation is effective in reducing car-
diac deaths. It is reasonable to promote exercise-based cardiac reha-
bilitation to patients similar to those included in the randomised
controlled trials - predominantly younger men who had suffered
myocardial infarction. There appears to be little to chose between
exercise only or more comprehensive rehabilitation, so it would
be rational to use cost considerations to determine practise. It is a
question of judgement whether such evidence is sufficient to base
extension of current practise to under-represented groups, such
as elderly people, women and those with angina, heart failure or
following revascularisation.
Implications for research
Larger scale well-designed and executed RCTs are needed to deter-
mine whether the effects of comprehensive rehabilitation found in
a heterogeneous set of small trials can be confirmed and extended
to other patient groups. A British NHS R&D funded trial has
recently been completed and its results are awaited with interest.
The population studied in this review is still predominately male,
middle aged and low risk. There has been little identification of
the ethnic origin of the participants. It is possible that patients who
would have benefited most from the intervention were excluded
from the trials on the grounds of age, sex or co-morbidity. These
groups should be included in future trials. The method of service
delivery, either through supervised settings, home-based services
or in combination, needs to be studied. Outcome measures that
accurately reflect the effect of rehabilitation on the patient and
their family need to be generated and used in everyday practice.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Anderson 81
Methods Post MI randomised 4 weeks after discharge. 88 participants were randomised, but 13 failed to follow up. Therefore
75 took part in the study
Participants 75 men < 66 yrs with 1st MI.
Mean age
I = 52.2 (+/-7.5),
C = 55.6 (+/-6.3).
Interventions Aerobic activity e.g. running, cycling, skipping + weights for 1 hour x 2 weekly for 2 months, then x 1 week for 10
months. Then continue at home.
F/U @ 1, 13, 25, & 37 months post discharge.
Outcomes Total & CHD mortality and non fatal MI.
Notes Several participants in C trained on own initiative, but were analysed as intention to treat.
Authors concluded that PT after MI appears to reduce consequences and to improve PWC, but PWC declines once
participant on their own.
PT had no effect on period of convalescence or return to work, but age and previous occupation were of significance.
A
Ballantyne 82
Methods Randomised 3 months post MI.
Participants 42 men < 65 yrs post MI.
Mean age
I = 51 (+/-5.2),
C =54.3 (+/-6.2)
Interventions Canadian Air Force 5BX Plan run by physiotherapists in a group.
F/U - 6 months
Outcomes Total, HDL, LDL cholesterol & triglycerides.
Notes After the study both groups increased their time to maximum exercise, more significantly in the trained group,
possibly due to familiarisation and greater physical confidence
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Bell 99
Methods Post MI
Randomised 4-6 days post event.
Participants 311 men / 89 women < 65 yrs.
Mean ages for women
60.7 (+/- 7.2) to 64.3 (+/-7.3),
for men
57.8(+/- 8.9) to 59.4 (+/- 9.4).
2 comparisons conventional CR v: the HM and HM v: control.
Interventions Conventional CR - 1 to 2 group classes per week, walking etc other days for 8-12 weeks with multidisciplinary team.
HM - individual - walking programme up to 6 weeks post MI, facilitator and written text.
F/U - 1 year.
Outcomes Total mortality,
SBP, DBP, smoking, total treadmill time, HRQoL.
Notes Hospital readmissions significantly reduced in HM group compared with conventional CR and control in initial 6
month period
Bengtsson 83
Methods Random allocation at time of event. 171 patients were randomised and at discharge the cardiologist decided whether
the patient was fit to take part in the rehab programme - 45 patients were excluded at this point. 7 of intervention
group declined to take part, but 6 of these were seen at follow up and included in the analysis because “control group
probably had a comparable number who would have declined further treatment.”
Participants 72 men / 13 women < 65 yrs following acute MI.
Mean age
I = 55.3 +/- 6.6,
C = 57.1 +/- 6.6.
Interventions Exercise intervention: physical training, interval training of large muscle groups, jogging, calisthenics. Co-interven-
tions:
counselling, social measures, group and individual.
F/U 14 months
Outcomes Total mortality, CHD mortality, non-fatal MI,
SBP, DBP, exercise tolerance
HRQoL; psychological tests.
Notes Most emphasis on social/ psychological aspects.
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Bertie 92
Methods Randomised on day of discharge after MI
Participants 110 participants men & women <65 yrs post MI.
Mean age
I = 52.1 +/- 1.3,
C = 52.7 +/- 1.3, range 32 - 64.
Interventions 2 x week for 4 weeks.
12 station circuit started 3 weeks post discharge.
F/U 12-24 months.
Outcomes Total mortality, non fatal MI, revascularisation
Notes At 4 months I walked farther & faster than C, with less breathlessness and angina in 12 min walking test and
pedometry. I also more likeky to be doing housework and resumed normal sexual activity at 4 months
Bethell 90
Methods Randomised 5 days post MI. 229 patients were randomised; 14 in the intervention group and 15 in control dropped
out before the first exercise test due to death, refusal or other problems. Therefore 200 took part in the study
Participants 200 men < 65 yrs post MI.
Mean age
I = 54.2 (+/-7.2), C = 53.2 (+/-7.7).
Interventions 3 x week for 3 months. 8 stage circuit aerobic & weight training. 70-85% predicted Hrmax.
11 year follow up published in 1999.
5 year follow up data from unpublished material used for meta analysis
Outcomes Total mortality, CHD mortality, non fatal MI,
smoking
Notes Cardiac mortality of 3% pa, once patients survived to be in the trial. Suggests more severely affected patients were
not included.
Significant predictors of cardiac death were pulmonary oedema on admission, complications during admission, one
or more previous infarcts, increasing age and low initial fitness
Carlsson 98 CABG
Methods Groups of 20 patients randomly allocated to intervention and control groups (usual care). Randomised 4 weeks post
discharge
In first 3 weeks post discharge all participants ( I & C) had 2 visits by nurse & 1 by cardiologist + all participants
invited to join regular exercise group x 1 per week for 30 mins information & 30 mins easy interval training
Participants Men & women aged 50 - 70 yrs with CABG (n = 67).
Mean age
I = 62.7 +/- 4.8,
C = 59.8 +/- 4.8.
17Exercise-based rehabilitation for coronary heart disease (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Carlsson 98 CABG (Continued)
Interventions Nurse counselling: 9 hours of counselling in individual & group sessions over 1 year; smoking cessation 1.5, dietary
management 5.5 & physical activity 2 hours.
After randomisation exercise programme 2-3 x weekly for 2-3 months. 40 mins of aerobic activity.
F/U 1 year
Outcomes Total cholesterol & LDL.
Notes Only 5 % over all on lipid lowerers at randomisation. At one year 82% of I on lipid lowering agents, and 28% of C
Carlsson 97
Methods Groups of 20 patients randomly allocated to intervention and control groups (usual care). Randomised 4 weeks post
discharge
In first 3 weeks post discharge all participants ( I & C) had 2 visits by nurse & 1 by cardiologist + all participants
invited to join regular exercise group x 1 per week for 30 mins information & 30 mins easy interval training
Participants 126 men and 42 women aged 50 years and older post MI.
Mean age
I = 62.2
C = 61.9
Interventions Exercise intervention:
exercise training, interval training with jogging and cycling.
Cointerventions:
counselling, smoking cessation and dietry advice, Control group: usual care. Follow up 1 year
Outcomes Physiological: Smoking and physical fitness (level of activity by questionnaire)
Notes Self report data. Rehabilitaion programme successful in improving food habits, but no advantage in supporting
physical activity compared to usual care
Carlsson 98 AMI
Methods Groups of 20 patients randomly allocated to intervention and control groups (usual care). Randomised 4 weeks post
discharge
In first 3 weeks post discharge all participants ( I & C) had 2 visits by nurse & 1 by cardiologist + all participants
invited to join regular exercise group x 1 per week for 30 mins information & 30 mins easy interval training
Participants Men & women aged 50 - 70 yrs with AMI (n = 168)
Mean age
I = 62.2 +/-5.8,
C = 61.7 +/-6,
Interventions Nurse counselling: 9 hours of counselling in individual & group sessions over 1 year; smoking cessation 1.5, dietary
management 5.5 & physical activity 2 hours.
After randomisation exercise programme 2-3 x weekly for 2-3 months. 40 mins of aerobic activity.
F/U 1 year
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Carlsson 98 AMI (Continued)
Outcomes Total cholesterol & LDL.
Notes Only 5 % over all on lipid lowerers at randomisation. At one year 75% pts in I on lipid lowering agents and 23% of
C
Carson 82
Methods Randomised 6 weeks post admission
Participants 303 men < 70 yrs with MI.
Mean age
I = 50.3 (SE 0.65) C=52.8 (SE 0.67)
Interventions Circuit 2 x weekly for 12 weeks.
F/U 2 years
Outcomes Total mortality, non fatal MI
Notes There appears to be a reduction in mortality in exercise participants with inferior MI
Engblom
Methods Randomised pre CABG
Participants 201 men & 27 women < 65 yrs with CABG.
Mean age = 54 +/- 6, range 40 - 64.
Interventions 4 stage rehab over 30 months starting pre CABG with meeting of physician, psychologist and
OT/PT.
6-8 weeks post CABG - 3 weeks IP with group sessions with psychologist, aerobic physical activity, relaxation &
group discussion.
8 months post CABG - 2 days meeting with OT, nutritionist, physician, physio.
30 months post CABG - one day with nutritionist, physician & exercise.
F/U I year & 6 years
Outcomes Lipids.
HRQoL;
Beck depression inventory.
Notes 5 years after CABG only 20% of participants were working, despite 90% of patients being in functional classes 1-2.
Almost half of patients had retired pre CABG. Many other factors affect RTW post CABG - age, education, physical
requirements of the job, type of occupation, self employed status, non work income, personality type, self perception
of working capacity and mostly length of absence from work pre CABG
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Erdman 86
Methods Randomised within 6 months of first MI.
Participants 80 men aged < 65 yrs (mean 51, range 35-60) within 6 months post MI. Also with CABG/angina.
Three psychologic inclusion criteria - one or more symptoms of the anxiety reaction, diminished self-esteem, positive
motivation to take part in the programme
Interventions Exercise intervention: fitness training, Cointerventions:
relaxation exercises.
Controls:
Usual care plus educational brochure with guidelines about physical fitness training.
Follow up 5 years.
Outcomes Smoking.
HRQoL
Notes Complex presentation of results.
Authors conclude that patients who will benefit from rehab can be detected on psychological grounds. Those who
have engaged in habitual exercise, but feel seriously disabled, yet do not feel inhibited in a group will benefit from
rehab
Fletcher 94
Methods Randomised at time of study.
Participants 88 men <73 yrs.
Mean age
I = 62 +/- 8,
C = 63 +/- 7 (range 42 - 72).
Participants had CAD and physical disability; CVA, amputee/musculoskeletal
Interventions Home exercise training programme using stationary wheelchair ergometer 20 mins/day, 5 days/week for 6 months
with telephone telemetry.
F/U 6 months.
Outcomes Total mortality, non fatal MI, non fatal stroke,
SBP, DBP.
Notes The treatment programme decreased myocardial oxygen demand.
Fridlund 91
Methods 178 patients randomised at time of MI. After randomisation & before start of study, 77 patients were excluded,
refused or died
Participants 101 men & 15 women < 65 yrs with MI.
Mean age 56.3.
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Fridlund 91 (Continued)
Interventions 2 hours x 1 weekly for 6 months. 1 hours exercise + 1 hours group discussion led by nurse.
F/U 1 & 5 years.
Outcomes Total mortality, non fatal MI, revascularisations
HRQoL:
WHO (Stocksmeier 79)
Notes Positive long term effects on physical condition, life habits, cardiac health knowledge. No effects found for cardiac
events or psychological condition
Heller 93
Methods Cluster by GP, randomisation on discharge.
Participants 323 men & 127 women < 70 yrs with MI.
Mean age
I = 59 +/- 8,
C = 58 +/- 8.
Interventions 3 letters to participant - information on fats, smoking and a walking programme.
F/U 6 months.
Outcomes Total mortality,
Total, HDL cholesterol,
smoking.
HRQoL:
Quality of Life after MI.
Notes Low use of preventative services (dietary, anti smoking) by both groups.
10% of patients received rehab - mostly having had CABG.
Holmback 94
Methods Randomised 6 weeks post MI.
Participants 67 men & 2 women <65 yrs
(mean age 55, range 38 - 63), post MI.
Interventions 12 weeks interval training (cycle, callisthenics, jogging & relaxation) for 45 mins x 2 weekly, starting 8 weeks post
MI.
F/U 1 year.
Outcomes Total mortality, non-fatal MI & revascularisation.
HRQoL:
Self report questionnaire.
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Holmback 94 (Continued)
Notes Authors found no benefit from exercise training. Outcomes were related to self-rated levels of physical and psycho-
logical well being
Kentala 72
Methods 298 patients were randomised by year of birth on admission with MI. Of these, 158 were accepted for follow up and
10 dropped out between being accepted for follow up and the start of the programme
Participants 148 men < 65 yrs with MI.
Mean age
I = 53, C = 52.8 (range 29 - 64).
Interventions 40 minutes exercise (10-relaxation, 10-warm up, 2 -cycling, stairs & rowing + cool down )., 2 x then 3 x weekly.
Encouraged to continue with 2 x 0.5 km walk daily.
F/U 1 year and 2 years for recurrent MI.
Outcomes Total & CHD mortality, non fatal MI.
SBP, DBP,
smoking
Notes No influence of ET on RTW.
No significant differences between groups - possibly because control group were fitter before MI or exercised anyway
Krachler 97
Methods No details of randomisation.
Participants all undergoing PTCA.
Participants 47 men & 13 women with CHD, undergoing PTCA.
Mean age 59 yrs.
Interventions Moderate exercise + diet.
F/U 1 year.
Outcomes Further need for PTCA.
Only baseline figures for SBP, total, HDL & LDL cholesterol, triglycerides
Notes I lost weight compared with C (p<0.01).
I had lower BP than C (p<0.01), and needed less revascularization over the year (10% of I, 42% of C)
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Lewin 92
Methods MI patients randomised 3 days post event, by stratified protocol
Participants 126 men & 50 women, mean age 55.8 yrs, post MI.
Interventions Heart manual: home based facilitated programme with manual and tapes, 3 stage exercise plan - home, walking and
life long, graded according to patient’s ability.
Control had placebo facilitator’s time.
F/U 1 year
Outcomes HRQoL;
HAD
GHQ
Notes Study terminated (due to expiry of funding) before all pts reached 6 or 12-month stage.
Anxiety scores showed significant treatment effect @ 6 weeks and 1 year, depression @ 6 weeks.
Pre hospital discharge 52% of all pts had HAD scores indicating clinically significant anxiety or depression (8+). C
were significantly more anxious and depressed at all follow ups
Lifestyle Heart
Methods 93 patients randomised and then invited to take part in the study, 48 accepted, 5 year results presented on 35
Participants 48 men & women aged 35 -75 yrs.
Mean age
I = 56.1 +/- 7,5,
C =59.8 +/- 9.1.
All had moderate to severe CAD (MI, PTCA, CABG, angina)
Interventions Exercise intervention: aerobic exercise, walking and jogging. Co-interventions: stress management, low fat vegetarian
diet, group psychosocial support .
Control group: usual care. Follow up 5 years.
Outcomes CHD mortality, non-fatal MI, revascularisation,
Physiological:
cholesterol, HDL, LDL, triglycerides, SBP, DBP.
Notes I had 91% reduction in reported frequency of angina after 1 year and 72% after 5, C had 186% increase in reported
frequency of angina after 1 year and 36% decrease after 5.
I had 7.9% relative improvement in coronary artery diameter at 5 years, C had 27.7% relative worsening @ 5 years
Miller/DeBusk 1A
Methods Randomised 3 weeks post MI
Participants 198 men < 70 yrs with MI.
Mean age 52 +/-9.
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Miller/DeBusk 1A (Continued)
Interventions Patients divided into 5 interventions;
1a-extended home
1b-brief home
2a-extended group
2b-brief group
3-ETT but no further training
4-no ETT or training.
Home; detailed instructions + HR monitors. If free of ETT induced angina @3 weeks pts used stationary bikes for
30 mins/day, 5 days/week.
If had ETT induced angina @ 3 weeks, brisk walking programme for 100 mins/week.
2x weekly telemetry to base from HR monitors. Brief intervention trained for 8 weeks, extended intervention for 23
weeks.
Group intervention trained in a group with clinical supervision for 8 or 23 weeks for 3 x 1 hour /week with 100
mins/week at training rate
All pts in 1a & b, 2 a & b and 3 received counselling from a physician (30-45 mins ) and nurse (30-45 mins).
F/U 23 weeks.
Outcomes CHD mortality, non fatal MI and revascularisation
Notes Low rate of cardiac events reflects identification of low risk population.
Group 3 were unexpectedly active, th authors concluding that ETT + good explanation may enhance physical activity
in the early stages
Miller/DeBusk 1B
Methods Randomised 3 weeks post MI
Participants 198 men < 70 yrs with MI.
Mean age 52 +/-9.
Interventions Patients divided into 5 interventions;
1a-extended home
1b-brief home
2a-extended group
2b-brief group
3-ETT but no further training
4-no ETT or training.
Home; detailed instructions + HR monitors. If free of ETT induced angina @3 weeks pts used stationary bikes for
30 mins/day, 5 days/week.
If had ETT induced angina @ 3 weeks, brisk walking programme for 100 mins/week.
2x weekly telemetry to base from HR monitors. Brief intervention trained for 8 weeks, extended intervention for 23
weeks.
Group intervention trained in a group with clinical supervision for 8 or 23 weeks for 3 x 1 hour /week with 100
mins/week at training rate
All pts in 1a & b, 2 a & b and 3 received counselling from a physician (30-45 mins ) and nurse (30-45 mins).
F/U 23 weeks.
Outcomes CHD mortality, non fatal MI and revascularisation
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Miller/DeBusk 1B (Continued)
Notes Low rate of cardiac events reflects identification of low risk population.
Group 3 were unexpectedly active, th authors concluding that ETT + good explanation may enhance physical activity
in the early stages
Miller/DeBusk 2A
Methods Randomised 3 weeks post MI
Participants 198 men < 70 yrs with MI.
Mean age 52 +/-9.
Interventions Patients divided into 5 interventions;
1a-extended home
1b-brief home
2a-extended group
2b-brief group
3-ETT but no further training
4-no ETT or training.
Home; detailed instructions + HR monitors. If free of ETT induced angina @3 weeks pts used stationary bikes for
30 mins/day, 5 days/week.
If had ETT induced angina @ 3 weeks, brisk walking programme for 100 mins/week.
2x weekly telemetry to base from HR monitors. Brief intervention trained for 8 weeks, extended intervention for 23
weeks.
Group intervention trained in a group with clinical supervision for 8 or 23 weeks for 3 x 1 hour /week with 100
mins/week at training rate
All pts in 1a & b, 2 a & b and 3 received counselling from a physician (30-45 mins ) and nurse (30-45 mins).
F/U 23 weeks.
Outcomes CHD mortality, non fatal MI and revascularisation
Notes Low rate of cardiac events reflects identification of low risk population.
Group 3 were unexpectedly active, th authors concluding that ETT + good explanation may enhance physical activity
in the early stages
Miller/DeBusk 2B
Methods Randomised 3 weeks post MI
Participants 198 men < 70 yrs with MI.
Mean age 52 +/-9.
Interventions Patients divided into 5 interventions;
1a-extended home
1b-brief home
2a-extended group
2b-brief group
3-ETT but no further training
25Exercise-based rehabilitation for coronary heart disease (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Miller/DeBusk 2B (Continued)
4-no ETT or training.
Home; detailed instructions + HR monitors. If free of ETT induced angina @3 weeks pts used stationary bikes for
30 mins/day, 5 days/week.
If had ETT induced angina @ 3 weeks, brisk walking programme for 100 mins/week.
2x weekly telemetry to base from HR monitors. Brief intervention trained for 8 weeks, extended intervention for 23
weeks.
Group intervention trained in a group with clinical supervision for 8 or 23 weeks for 3 x 1 hour /week with 100
mins/week at training rate
All pts in 1a & b, 2 a & b and 3 received counselling from a physician (30-45 mins ) and nurse (30-45 mins).
F/U 23 weeks.
Outcomes CHD mortality, non fatal MI and revascularisation
Notes Low rate of cardiac events reflects identification of low risk population.
Group 3 were unexpectedly active, th authors concluding that ETT + good explanation may enhance physical activity
in the early stages
NEHDP
Methods Participants treated at one of 5 participating centres. Participants randomised after participating in low level exercise
course for 6 weeks
Participants 651 men aged 30 - 64 yrs with MI between 8 weeks and 3 years prior to start of study (mean 14 months).
Mean age
I = 51.5+/- 7.4,
C = 52.1 +/- 7.2
Interventions ET- 1 hour/day, 3 days/week for 8 weeks. 6 station circuit + gym exercises or swimming and games.
F/U 3 years.
Long term follow up to 19 years published in 1999, but not used for meta analysis
Outcomes Total & CHD mortality, non fatal MI
Various psychological measures.
Notes 90% of ET attended 90% of 24 scheduled sessions post randomisation, only 48% attending > 50% of sessions at 18
months.
30% of control alleged exercising regularly, on own initiative.
At 19 years any protective
effect form the programme had decreased over time, but an increase with PWC from the beginning to the end of the
trial was associates with a consistent reduction in mortality throughout the 19 years of follow up
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Oldridge 91
Methods Stratified by status (work type and employed or not) and randomised at time of MI. All participants were depressed
and/or anxious (Beck Depression Inventory <5, < 43 on Spielberger State Anxiety Inventory, or <42 on Spielberger
Trait Anxiety Inventory.)
Participants 177 men & 24 women with MI. Mean age
I =52.9+/- 9.5 yrs,
C = 52.7 +/- 9.5 yrs.
Interventions ET for participant & spouse.
50 minutes 2 x weekly for 8 weeks at 65% of HRmax during ETT.
Plus cognitive behavioural group intervention of 8 sessions of 1.5 hours + relaxation.
CPR training offered to spouse.
F/U 1 year.
Outcomes Mortality
HRQoL:
QoLAMI
Quality of well being.
Time trade-off.
Notes Both groups improved over 12 months, with the biggest changes occurring in the first 8 weeks
PRECOR
Methods Randomised 30 -60 days post MI into usual care, exercise based rehab programme or counselling programme
Participants 182 men < 65 with MI.
Mean age
I = 51, C = 49 yrs.
Interventions RP - 3 sessions per week for 6 weeks + relaxation, education on risk factors and recommendation for continuing
exercise.
F/U 2 years
Outcomes Non fatal MI, angina, surgery,
smoking
Notes Only 14% of all MI patients admitted to the participating hospitals were randomised to the trial. Exclusion of women
and patients >65 accounted for 60% of exclusions
Schuler/Niebauer
Methods Participants randomised after routine angiography for angina. 66% study population had previous MI.
All participants spent one week as inpatient on a metabolic ward receiving instruction on exercise and diet
Participants 113 men with CAD, aged 35 - 68 yrs (mean 53.5)
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Schuler/Niebauer (Continued)
Interventions 2 further weeks as IP, then daily exercise at home on cycle (30 mins at 75% HR max) + 2 group training sessions of
60 mins/week. Informative session held 5 times/year for participants and spouses.
F/U yearly for 6 years.
Outcomes Total and CHD mortality, non fatal MI, revascularisation,
total, HDL & LDL cholesterol, triglycerides,
coronary artery diameter
Notes Exercise adherence in the first year was 68% (39-92%, over the next 5 years 33% (3-89%).
Pts with regression of coronary atheroma attended exercise sessions significantly more often (54+/- 24%) than patients
with no change (20+/- 24%) or progression 31+/- 20%)
SCRIP
Methods Participants randomised after angiography at one of four hospitals
Participants 259 men & 41 women with CAD < 75 yrs.
Mean age
I = 58.3 =/- 9.2,
C = 56.2 +/- 8.2.
Interventions Nurse managed, home based programme based on Miller, with specific goals to be attained.
F/U 4 years.
Outcomes Total & CHD mortality, non fatal MI & stroke, revascularisation,
SDP, DBP, smoking, total, HDL, LDL cholesterol,
coronary artery diameter.
Notes The rate of change in the minimal coronary artery diameter was 47% less in I than C. This was still significant when
adjusted for age and baseline segment diameter (p=0.03)
Sivarajan 82
Methods Multicentre study. Random allocation of individuals to two intervention groups (exercise only or exercise plus teaching
and counselling) and a control group (usual care)
Participants 258 patients (>80% men) aged <71 yrs.
Mean age
I = 55.6+/- 9.3, 56.3 +/- 8.3,
C = 57.1 +/- 7.3. Following acute MI.
Interventions All patients exercise whilst in hospital.
Ex only:
Weekly clinic appointments 3 months post discharge for progressive calisthenics and walking. Exercise 2 x daily until
RTW and then x 1 daily.
Ex + T&C:
Same exercise programme + 8 x 1 hour teaching/ counselling sessions with family & friends
28Exercise-based rehabilitation for coronary heart disease (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sivarajan 82 (Continued)
F/U 6 months.
Outcomes Total mortality,
smoking, physical fitness (distance HRQoL;
Sickness Impact Profile.
Notes Several reports of the same trial all with various bits of information. Authors conclude that multiple intervention
trial of this short duration did not change patient’s behaviour. MI itself acts as a strong stimulus to alter behaviour
with respect to risk factors
Sivarajan 82 ex plus
Methods Multicentre study. Random allocation of individuals to two intervention groups (exercise only or exercise plus teaching
and counselling) and a control group (usual care)
Participants 258 patients (>80% men) aged <71 yrs.
Mean age
I = 55.6+/- 9.3, 56.3 +/- 8.3,
C = 57.1 +/- 7.3. Following acute MI.
Interventions All patients exercise whilst in hospital.
Ex only:
Weekly clinic appointments 3 months post discharge for progressive calisthenics and walking. Exercise 2 x daily until
RTW and then x 1 daily.
Ex + T&C:
Same exercise programme + 8 x 1 hour teaching/ counselling sessions with family & friends
F/U 6 months.
Outcomes Total mortality,
smoking, physical fitness (distance HRQoL;
Sickness Impact Profile.
Notes Several reports of the same trial all with various bits of information. Authors conclude that multiple intervention
trial of this short duration did not change patient’s behaviour. MI itself acts as a strong stimulus to alter behaviour
with respect to risk factors
Speccia 96
Methods Randomised at hospital discharge.
All participants went to a rehab centre for 3weeks for ETT, 24 hour tape. All participants had sessionswith cardiologist
& psychologist for secondary prevention advice
Participants 182 men & 18 women < 65 yrs with MI.
Mean age
I = 51.5 +/- 7,
C = 54.3 +/- 8.
29Exercise-based rehabilitation for coronary heart disease (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Speccia 96 (Continued)
Interventions 4 weeks supervised cycling for 30 mins 5 days/week + calisthenics @ 75% max work capacity. After discharge to walk
for 30 minutes every 2 days.
F/U 34 months.
Outcomes CHD mortality, revascularisations
Notes Ejection fraction was the only prognostic factor.
Among 51 patients with EF <41%, relative risk for the 27 untrained participants was 8.63 times higher than for 24
trained ones. (p=0.04)
If EF > 40%, estimated risk for untrained participant was 1.07 times higher than for trained
Stern 83
Methods Randomized by blocks of 6 into one of three groups: exercise, group counselling & control.
Eligibility - work capacity <7 METs (men), <6 METs (women), Taylor Manifest Anxiety Scale raw score of 19+ and/
or Zung self rating Depression Scale raw score of 40+
Participants 91 men & 15 women aged 30-60 yrs with MI between 6 weeks and 1 year prior to entry to study
Interventions 3 x 1 hour sessions/week over 12 week period for 36 sessions.
All exercises dynamic against resistance, exercising upper limb and lower limb alternately for 4 minutes with 2 mins
rest in between. Target HR 85% of HRmax at ETT.
F/U 1 year.
Outcomes Psychological scales, work capacity.
Notes Minimal differences between groups at one year.
Taylor 97
Methods Randomised 3rd day post MI.
Participants 294 men & 8 women F <70 yrs (mean age 57+/- 8), post MI, in 5 centres
Interventions Nurse managed, home based, multifactorial risk factor intervention programme with exercise training based on De
Busk/Miller. F/U 12 months
Outcomes Total mortality
HRQoL:
Single item rating scales.
Notes Levels of psychological distress dropped significantly for both groups by 12 months
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Vecchio 81
Methods Randomised after ETT, 30 days after MI.
Participants 50 patients aged 40 to 60 yrs with MI (mean 50.1).
Interventions 6 weeks physical training programme.
F/U 1 year.
Outcomes Physical work capacity, clinical events.
Notes Trained patients showed a better mid term prognosis than controls, but this could not be explained by the physical
training procedure
Vermuelen 83
Methods Randomised 4-6 weeks post MI after ETT.
Participants 98 men aged 40- 55 yrs with MI. Mean age
I = 49.4 +/- 3.7,
C = 49.1 +/- 4.5.
Interventions Rehabilitation programme.
F/U 5 years
Outcomes Morbidity & mortality,
Smoking,
cholesterol
Notes Authors conclude that cardiac rehab benefits patients after MI due to direct effect on myocardial perfusion and to
lowering of cholesterol levels
WHO Balatonfured
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 160 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 6 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
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WHO Balatonfured (Continued)
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Brussels
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 166 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 8 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Bucharest
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 129 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 12 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
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WHO Budapest
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 200 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 8 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Dessau
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 54 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 6 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
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WHO Erfut
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 119 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 5 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Ghent
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 168 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 6 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
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WHO Helsinki
Methods Part of WHO trial published separately. Randomised 2 weeks post MI
Participants 301 men & 74 women < 65 yrs with MI.
Mean age
I = 53(F), 58.4 (M),
C = 53.4 (F), 58 (M).
Interventions Medical exam, health education, discussion of psychosocial problems + tailored exercise programme, mostly under
supervision. Most intense for first 3 months - no details. F/U 3, 10 & 15 years. Only 3 year follow up used for meta
analysis
Outcomes Total & CHD mortality, non fatal MI,
SBP, lipids,
smoking.
Notes I increased therapeutic intervention over 3 years, particularly beta blockers
WHO Kaunas
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 115 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 8 -16 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Prague
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 112 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
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WHO Prague (Continued)
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training continuously for the period of the study.
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Rome
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 63 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training for 8 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Tel Aviv
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 114 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
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WHO Tel Aviv (Continued)
Local training for 20 weeks
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
WHO Warsaw
Methods 24 centre, pan European study conducted between 1973 and 1978. Randomised on discharge from hospital. 12
centres accepted for meta analysis
Participants 79 Men < 65 yrs with first or consecutive MI.
Mean age for all participants
I = 52.3, C = 53.5.
Interventions Comprehensive programme dependent on local provision. Physical training was not compulsory but was strongly
recommended.
F/U 3 years
Local training full time.
Outcomes Clinical:
Total, CVD, CHD & sudden death.
Fatal & non fatal re-infarction.
RTW, RPP,anxiety & depression, incidence of angina or heart failure at follow up not included in meta-analysis
Notes Methodological problems with the execution of the study allowed only death and reinfarction to be successfully used
as endpoints
Wilhelmson 75
Methods Randomised on discharge. All patients received information on increasing physical activity during convalescence
Participants 280 men & 35 women < 55 yrs with MI.
Mean age 50.6.
Interventions Training programme 3 months after MI, 3 x half hour sessions per week based in hospital, at home or in workplace.
F/U 5 years
Outcomes Mortality, re-infarction.
Notes 1 year post MI, 39% of those who started training were training at the hospital. A further 21% trained at home or
at work
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Worsornu 96
Methods Random allocation of individuals to intervention and control groups (usual care)
Participants 81 men aged 57.4 (+/-7.6) yrs, post CABG
Interventions Exercise intervention:
Two interventions, aerobic and strength exercise training
Control group: usual care. Follow up period 6 months
Outcomes Cholesterol, HDL, LDL, triglycerides, exercise capacity
Notes Primary focus of paper - comparing strength and aerobic exercise training on exercise capacity (outcome 1) and lipid
levels (outcome 2) post CABG
MI: Myocardial infarction
CHD: Coronary heart disease
SBP: Systolic blood pressure
DBP: Diastolic blood pressure
HDL: High density lipoprotein
LDL: Low density lipoprotein
QoL: Quality of life
V02max: Maximum oxygen uptake
CV: Cardiovascular
PWC: physical work capacity.
ET: exercise training
RTW: return to work
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bar 92 Method of randomisation was inadequate in that of a study population of 265 across 5 centres only one centre
randomised their patients, leaving a control group of 50 and an intervention group of 215
Bjorntorp 72 Participants randomised alternately after admission.
Blumenthal 97 Control group was not randomised, but selected on geographical basis
Nikolaus 91 Participants were a subgroup of Schuler study and have already been included
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D A T A A N D A N A L Y S E S
Comparison 1. Exercise only versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Total Mortality 12 2582 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.74 [0.56, 0.98]
2 Total Cardiac Deaths 8 2312 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.70 [0.51, 0.94]
3 Non fatal MI 9 2104 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.96 [0.69, 1.35]
4 Pooled mortality, non-fatal MI,
CABG, PTCA
12 2582 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.81 [0.65, 1.01]
5 Total Cholesterol 3 237 Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.27, 0.22]
6 LDL Cholesterol 2 95 Mean Difference (IV, Fixed, 95% CI) -0.02 [-0.33, 0.30]
Comparison 2. Exercise plus other rehabilitation versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Total Mortality 29 5101 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.87 [0.71, 1.05]
2 Total Cardiac Deaths 22 2903 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.75 [0.59, 0.97]
3 Non fatal MI 26 3541 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.88 [0.70, 1.12]
4 Pooled mortality, non-fatal MI,
CABG, PTCA
29 5101 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.81 [0.70, 0.93]
5 Total Cholesterol 9 1198 Mean Difference (IV, Fixed, 95% CI) -0.65 [-0.75, -0.55]
6 LDL Cholesterol 6 728 Mean Difference (IV, Fixed, 95% CI) -0.61 [-0.73, -0.50]
Comparison 3. Any rehabilitation intervention including exercise versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pooled mortality, non-fatal MI,
CABG, PTCA
41 7683 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.81 [0.72, 0.91]
2 Quality criteria - Random
allocation: Outcome total
mortality
41 7683 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.82 [0.70, 0.97]
2.1 Clear description -
adequate randomisation
12 3201 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.79 [0.62, 1.00]
2.2 Unclear description of
method of randomisation
27 4006 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.88 [0.70, 1.10]
2.3 Clear description -
inadequate randomisation
2 476 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.53 [0.20, 1.40]
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3 Quality criteria - Loss to follow
up: Outcome total mortality
41 7683 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.82 [0.70, 0.97]
3.1 Less than 20% loss to
follow up
27 5157 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.84 [0.69, 1.00]
3.2 Greater than 20% loss to
follow up
14 2526 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.79 [0.57, 1.09]
4 Quality criteria - Blind
assessment of outcomes
41 7683 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.82 [0.70, 0.97]
4.1 Yes - clearly described 9 2225 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.78 [0.54, 1.12]
4.2 Unclear 32 5458 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.83 [0.70, 1.00]
Analysis 1.1. Comparison 1 Exercise only versus usual care, Outcome 1 Total Mortality.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 1 Total Mortality
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Anderson 81 4/46 3/42 3.4 % 1.23 [ 0.27, 5.74 ]
Bethell 90 16/113 12/116 12.9 % 1.42 [ 0.65, 3.14 ]
Carson 82 12/151 21/152 15.5 % 0.55 [ 0.27, 1.13 ]
Erdman 86 4/40 0/40 2.0 % 8.00 [ 1.08, 58.98 ]
Holmback 94 1/34 1/35 1.0 % 1.03 [ 0.06, 16.81 ]
Kentala 72 5/152 8/146 6.5 % 0.59 [ 0.20, 1.80 ]
NEHDP 15/323 24/328 19.2 % 0.62 [ 0.33, 1.19 ]
Sivarajan 82 3/88 2/84 2.6 % 1.44 [ 0.24, 8.47 ]
Speccia 96 5/125 13/131 8.8 % 0.41 [ 0.16, 1.06 ]
Stern 83 0/42 1/29 0.5 % 0.09 [ 0.00, 4.66 ]
Vecchio 81 0/25 2/25 1.0 % 0.13 [ 0.01, 2.14 ]
Wilhelmson 75 28/158 35/157 26.5 % 0.75 [ 0.43, 1.31 ]
Total (95% CI) 1297 1285 100.0 % 0.74 [ 0.56, 0.98 ]
Total events: 93 (Treatment), 122 (Control)
Heterogeneity: Chi2 = 14.33, df = 11 (P = 0.22); I2 =23%
Test for overall effect: Z = 2.09 (P = 0.037)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.2. Comparison 1 Exercise only versus usual care, Outcome 2 Total Cardiac Deaths.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 2 Total Cardiac Deaths
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Anderson 81 4/46 3/42 3.8 % 1.23 [ 0.27, 5.74 ]
Bethell 90 13/113 12/116 13.2 % 1.13 [ 0.49, 2.58 ]
Carson 82 12/151 21/152 17.4 % 0.55 [ 0.27, 1.13 ]
Kentala 72 5/152 7/146 6.8 % 0.68 [ 0.21, 2.15 ]
NEHDP 14/323 20/328 19.1 % 0.70 [ 0.35, 1.40 ]
Sivarajan 82 3/88 1/84 2.3 % 2.64 [ 0.37, 19.09 ]
Speccia 96 5/125 13/131 9.9 % 0.41 [ 0.16, 1.06 ]
Wilhelmson 75 23/158 33/157 27.3 % 0.64 [ 0.36, 1.15 ]
Total (95% CI) 1156 1156 100.0 % 0.70 [ 0.51, 0.94 ]
Total events: 79 (Treatment), 110 (Control)
Heterogeneity: Chi2 = 5.30, df = 7 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.3. Comparison 1 Exercise only versus usual care, Outcome 3 Non fatal MI.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 3 Non fatal MI
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Anderson 81 3/46 6/42 6.1 % 0.43 [ 0.11, 1.71 ]
Bethell 90 9/113 14/116 15.6 % 0.64 [ 0.27, 1.50 ]
Carson 82 11/151 10/152 14.7 % 1.12 [ 0.46, 2.70 ]
Erdman 86 2/40 1/40 2.2 % 1.98 [ 0.20, 19.62 ]
Holmback 94 2/34 0/35 1.5 % 7.84 [ 0.48, 128.05 ]
Kentala 72 5/152 4/146 6.6 % 1.21 [ 0.32, 4.54 ]
NEHDP 15/323 11/328 18.8 % 1.40 [ 0.64, 3.06 ]
Stern 83 1/42 1/29 1.4 % 0.68 [ 0.04, 11.65 ]
Wilhelmson 75 25/158 28/157 33.2 % 0.87 [ 0.48, 1.56 ]
Total (95% CI) 1059 1045 100.0 % 0.96 [ 0.69, 1.35 ]
Total events: 73 (Treatment), 75 (Control)
Heterogeneity: Chi2 = 6.01, df = 8 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.83)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Exercise only versus usual care, Outcome 4 Pooled mortality, non-fatal MI,
CABG, PTCA.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 4 Pooled mortality, non-fatal MI, CABG, PTCA
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Anderson 81 7/46 9/42 4.2 % 0.66 [ 0.23, 1.95 ]
Bethell 90 25/113 26/116 12.6 % 0.98 [ 0.53, 1.83 ]
Carson 82 23/151 31/152 14.1 % 0.70 [ 0.39, 1.27 ]
Erdman 86 6/40 1/40 2.0 % 4.69 [ 1.00, 21.92 ]
Holmback 94 3/34 2/35 1.5 % 1.58 [ 0.26, 9.61 ]
Kentala 72 10/152 12/146 6.5 % 0.79 [ 0.33, 1.87 ]
NEHDP 30/323 35/328 18.5 % 0.86 [ 0.51, 1.43 ]
Sivarajan 82 7/88 10/84 4.9 % 0.64 [ 0.24, 1.75 ]
Speccia 96 17/125 21/131 10.3 % 0.83 [ 0.42, 1.64 ]
Stern 83 2/42 3/29 1.4 % 0.43 [ 0.07, 2.71 ]
Vecchio 81 0/25 3/25 0.9 % 0.12 [ 0.01, 1.25 ]
Wilhelmson 75 53/158 63/157 23.2 % 0.75 [ 0.48, 1.19 ]
Total (95% CI) 1297 1285 100.0 % 0.81 [ 0.65, 1.01 ]
Total events: 183 (Treatment), 216 (Control)
Heterogeneity: Chi2 = 9.57, df = 11 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.059)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Exercise only versus usual care, Outcome 5 Total Cholesterol.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 5 Total Cholesterol
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ballantyne 82 19 -0.18 (0.65) 23 0.05 (0.92) 26.4 % -0.23 [ -0.71, 0.25 ]
Kentala 72 69 0.7 (1.12) 73 0.77 (0.96) 50.5 % -0.07 [ -0.41, 0.27 ]
Worsornu 96 26 0 (0.94) 27 -0.3 (0.95) 23.1 % 0.30 [ -0.21, 0.81 ]
Total (95% CI) 114 123 100.0 % -0.03 [ -0.27, 0.22 ]
Heterogeneity: Chi2 = 2.34, df = 2 (P = 0.31); I2 =15%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Exercise only versus usual care, Outcome 6 LDL Cholesterol.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 1 Exercise only versus usual care
Outcome: 6 LDL Cholesterol
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ballantyne 82 19 -0.34 (0.75) 23 0.05 (0.78) 45.7 % -0.39 [ -0.85, 0.07 ]
Worsornu 96 26 -0.1 (0.79) 27 -0.4 (0.79) 54.3 % 0.30 [ -0.13, 0.73 ]
Total (95% CI) 45 50 100.0 % -0.02 [ -0.33, 0.30 ]
Heterogeneity: Chi2 = 4.61, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 0.09 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 1 Total Mortality.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 1 Total Mortality
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Bell 99 8/102 8/102 3.7 % 1.00 [ 0.36, 2.77 ]
Bengtsson 83 10/81 6/90 3.6 % 1.95 [ 0.70, 5.44 ]
Bertie 92 0/57 3/53 0.7 % 0.12 [ 0.01, 1.19 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 1.0 % 0.98 [ 0.14, 7.05 ]
Engblom 12/119 13/109 5.6 % 0.83 [ 0.36, 1.90 ]
Fletcher 94 3/41 4/47 1.6 % 0.85 [ 0.18, 3.97 ]
Fridlund 91 1/87 3/91 1.0 % 0.38 [ 0.05, 2.73 ]
Heller 93 6/213 3/237 2.2 % 2.20 [ 0.59, 8.25 ]
Lifestyle Heart 2/53 1/40 0.7 % 1.50 [ 0.15, 15.10 ]
Oldridge 91 3/99 4/102 1.7 % 0.77 [ 0.17, 3.46 ]
PRECOR 0/60 4/61 1.0 % 0.13 [ 0.02, 0.95 ]
Schuler/Niebauer 5/56 8/57 2.9 % 0.61 [ 0.19, 1.92 ]
SCRIP 3/145 3/155 1.5 % 1.07 [ 0.21, 5.38 ]
Sivarajan 82 3/86 2/84 1.2 % 1.47 [ 0.25, 8.67 ]
Taylor 97 13/293 10/292 5.5 % 1.31 [ 0.57, 3.01 ]
WHO Balatonfured 9/80 9/80 4.0 % 1.00 [ 0.38, 2.66 ]
WHO Brussels 14/85 22/81 7.1 % 0.53 [ 0.26, 1.12 ]
WHO Bucharest 8/65 10/64 3.9 % 0.76 [ 0.28, 2.05 ]
WHO Budapest 21/101 17/99 7.7 % 1.26 [ 0.62, 2.56 ]
WHO Dessau 2/29 4/25 1.3 % 0.40 [ 0.07, 2.18 ]
WHO Erfut 11/63 12/56 4.6 % 0.78 [ 0.31, 1.93 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
WHO Ghent 15/84 3/84 4.0 % 4.41 [ 1.66, 11.70 ]
WHO Helsinki 41/188 56/187 18.0 % 0.65 [ 0.41, 1.04 ]
WHO Kaunas 14/66 12/49 4.9 % 0.83 [ 0.34, 2.00 ]
WHO Prague 9/59 11/53 4.1 % 0.69 [ 0.26, 1.81 ]
WHO Rome 7/34 6/29 2.6 % 0.99 [ 0.30, 3.35 ]
WHO Tel Aviv 5/63 4/51 2.1 % 1.01 [ 0.26, 3.96 ]
WHO Warsaw 1/39 7/40 1.8 % 0.20 [ 0.05, 0.85 ]
Total (95% CI) 2566 2535 100.0 % 0.87 [ 0.71, 1.05 ]
Total events: 228 (Treatment), 247 (Control)
Heterogeneity: Chi2 = 33.52, df = 27 (P = 0.18); I2 =19%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 2 Total Cardiac
Deaths.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 2 Total Cardiac Deaths
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Lifestyle Heart 2/53 1/40 1.2 % 1.50 [ 0.15, 15.10 ]
Miller/DeBusk 1A 0/33 1/37 0.4 % 0.15 [ 0.00, 7.65 ]
Miller/DeBusk 1B 0/33 1/37 0.4 % 0.15 [ 0.00, 7.65 ]
Miller/DeBusk 2A 0/30 1/37 0.4 % 0.16 [ 0.00, 8.42 ]
Miller/DeBusk 2B 0/31 1/37 0.4 % 0.16 [ 0.00, 8.15 ]
Schuler/Niebauer 5/56 2/57 2.7 % 2.52 [ 0.55, 11.56 ]
SCRIP 2/145 3/155 2.0 % 0.71 [ 0.12, 4.17 ]
Sivarajan 82 3/86 1/84 1.6 % 2.70 [ 0.37, 19.53 ]
Vermuelen 83 2/47 5/51 2.7 % 0.44 [ 0.09, 2.02 ]
WHO Balatonfured 6/80 8/80 5.2 % 0.73 [ 0.25, 2.19 ]
WHO Brussels 7/85 12/81 6.9 % 0.52 [ 0.20, 1.36 ]
WHO Bucharest 6/65 7/64 4.8 % 0.83 [ 0.26, 2.60 ]
WHO Budapest 18/101 15/99 11.2 % 1.21 [ 0.58, 2.55 ]
WHO Dessau 1/29 4/25 1.9 % 0.23 [ 0.04, 1.44 ]
WHO Erfut 11/63 12/56 7.6 % 0.78 [ 0.31, 1.93 ]
WHO Ghent 6/84 0/84 2.4 % 7.86 [ 1.55, 39.91 ]
WHO Helsinki 35/188 55/187 27.8 % 0.55 [ 0.35, 0.89 ]
WHO Kaunas 13/66 11/49 7.6 % 0.85 [ 0.34, 2.10 ]
WHO Prague 8/59 10/53 6.2 % 0.68 [ 0.25, 1.85 ]
WHO Rome 1/34 1/29 0.8 % 0.85 [ 0.05, 14.03 ]
WHO Tel Aviv 6/63 3/51 3.4 % 1.64 [ 0.42, 6.42 ]
WHO Warsaw 1/39 6/40 2.6 % 0.22 [ 0.05, 1.02 ]
Total (95% CI) 1470 1433 100.0 % 0.75 [ 0.59, 0.97 ]
Total events: 133 (Treatment), 160 (Control)
Heterogeneity: Chi2 = 24.54, df = 21 (P = 0.27); I2 =14%
Test for overall effect: Z = 2.23 (P = 0.026)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 3 Non fatal MI.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 3 Non fatal MI
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Bengtsson 83 2/81 4/90 2.1 % 0.56 [ 0.11, 2.85 ]
Bertie 92 0/57 1/53 0.4 % 0.13 [ 0.00, 6.34 ]
Engblom 8/119 16/109 7.7 % 0.43 [ 0.19, 1.00 ]
Fridlund 91 4/87 14/91 5.8 % 0.31 [ 0.12, 0.81 ]
Lifestyle Heart 2/53 4/40 2.0 % 0.36 [ 0.07, 1.90 ]
Miller/DeBusk 1A 2/33 3/37 1.7 % 0.74 [ 0.12, 4.50 ]
Miller/DeBusk 1B 1/33 3/37 1.4 % 0.39 [ 0.05, 2.94 ]
Miller/DeBusk 2A 1/30 3/37 1.4 % 0.43 [ 0.06, 3.25 ]
Miller/DeBusk 2B 1/31 3/37 1.4 % 0.42 [ 0.06, 3.14 ]
PRECOR 4/60 6/61 3.3 % 0.66 [ 0.18, 2.40 ]
Schuler/Niebauer 3/56 4/57 2.4 % 0.75 [ 0.16, 3.45 ]
SCRIP 4/145 10/155 4.8 % 0.44 [ 0.15, 1.28 ]
Vermuelen 83 4/47 9/51 4.1 % 0.46 [ 0.14, 1.46 ]
WHO Balatonfured 7/80 0/80 2.4 % 7.99 [ 1.76, 36.19 ]
WHO Brussels 11/85 2/81 4.3 % 4.23 [ 1.37, 13.08 ]
WHO Bucharest 8/65 13/64 6.4 % 0.56 [ 0.22, 1.42 ]
WHO Budapest 17/101 12/99 9.0 % 1.46 [ 0.67, 3.20 ]
WHO Dessau 2/29 3/25 1.7 % 0.55 [ 0.09, 3.43 ]
WHO Erfut 2/63 3/56 1.7 % 0.58 [ 0.10, 3.49 ]
WHO Ghent 4/84 9/84 4.3 % 0.44 [ 0.14, 1.35 ]
WHO Helsinki 36/188 21/187 17.4 % 1.85 [ 1.05, 3.24 ]
WHO Kaunas 5/66 5/49 3.2 % 0.72 [ 0.20, 2.66 ]
WHO Prague 6/59 9/53 4.7 % 0.56 [ 0.19, 1.65 ]
WHO Rome 1/34 0/29 0.4 % 6.38 [ 0.13, 325.47 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
WHO Tel Aviv 9/63 4/51 4.1 % 1.88 [ 0.59, 5.98 ]
WHO Warsaw 5/39 1/40 2.0 % 4.27 [ 0.82, 22.34 ]
Total (95% CI) 1788 1753 100.0 % 0.88 [ 0.70, 1.12 ]
Total events: 149 (Treatment), 162 (Control)
Heterogeneity: Chi2 = 47.95, df = 25 (P = 0.004); I2 =48%
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 4 Pooled
mortality, non-fatal MI, CABG, PTCA.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 4 Pooled mortality, non-fatal MI, CABG, PTCA
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Bell 99 8/102 8/102 2.0 % 1.00 [ 0.36, 2.77 ]
Bengtsson 83 12/81 10/90 2.7 % 1.39 [ 0.57, 3.40 ]
Bertie 92 1/57 4/53 0.7 % 0.27 [ 0.04, 1.59 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 0.5 % 0.98 [ 0.14, 7.05 ]
Engblom 29/119 35/109 6.4 % 0.68 [ 0.38, 1.22 ]
Fletcher 94 3/41 4/47 0.9 % 0.85 [ 0.18, 3.97 ]
Fridlund 91 26/87 39/91 5.7 % 0.57 [ 0.31, 1.05 ]
Heller 93 46/213 54/237 10.7 % 0.93 [ 0.60, 1.46 ]
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Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Lifestyle Heart 14/53 24/40 3.1 % 0.25 [ 0.11, 0.58 ]
Oldridge 91 3/99 4/102 0.9 % 0.77 [ 0.17, 3.46 ]
PRECOR 6/60 11/61 2.0 % 0.52 [ 0.19, 1.44 ]
Schuler/Niebauer 20/56 25/57 3.8 % 0.71 [ 0.34, 1.51 ]
SCRIP 26/145 44/155 7.4 % 0.56 [ 0.33, 0.95 ]
Sivarajan 82 10/86 10/84 2.4 % 0.97 [ 0.38, 2.47 ]
Taylor 97 13/293 10/292 3.1 % 1.31 [ 0.57, 3.01 ]
WHO Balatonfured 16/80 9/80 2.9 % 1.93 [ 0.83, 4.53 ]
WHO Brussels 25/85 24/81 4.8 % 0.99 [ 0.51, 1.92 ]
WHO Bucharest 16/65 23/64 3.8 % 0.59 [ 0.28, 1.24 ]
WHO Budapest 38/101 29/99 6.2 % 1.45 [ 0.81, 2.61 ]
WHO Dessau 4/29 7/25 1.2 % 0.42 [ 0.11, 1.58 ]
WHO Erfut 13/63 15/56 3.0 % 0.71 [ 0.31, 1.66 ]
WHO Ghent 19/84 12/84 3.5 % 1.73 [ 0.80, 3.77 ]
WHO Helsinki 41/188 56/187 10.0 % 0.65 [ 0.41, 1.04 ]
WHO Kaunas 19/66 17/49 3.4 % 0.76 [ 0.34, 1.68 ]
WHO Prague 15/59 20/53 3.3 % 0.57 [ 0.26, 1.26 ]
WHO Rome 8/34 6/29 1.5 % 1.18 [ 0.36, 3.83 ]
WHO Tel Aviv 14/63 8/51 2.4 % 1.52 [ 0.60, 3.85 ]
WHO Warsaw 6/39 8/40 1.6 % 0.73 [ 0.23, 2.31 ]
Total (95% CI) 2566 2535 100.0 % 0.81 [ 0.70, 0.93 ]
Total events: 453 (Treatment), 518 (Control)
Heterogeneity: Chi2 = 34.08, df = 27 (P = 0.16); I2 =21%
Test for overall effect: Z = 2.88 (P = 0.0040)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 5 Total
Cholesterol.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 5 Total Cholesterol
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlsson 98 CABG 31 -0.45 (1.22) 32 0.73 (1.28) 2.6 % -1.18 [ -1.80, -0.56 ]
Carlsson 98 AMI 75 -0.79 (0.97) 67 0.11 (0.79) 11.7 % -0.90 [ -1.19, -0.61 ]
Engblom 98 -0.91 (0.97) 82 -0.9 (0.94) 12.5 % -0.01 [ -0.29, 0.27 ]
Fletcher 94 41 -0.18 (0.77) 47 0.41 (0.73) 9.9 % -0.59 [ -0.90, -0.28 ]
Lifestyle Heart 20 -0.96 (0.92) 15 -0.8 (0.68) 3.5 % -0.16 [ -0.69, 0.37 ]
Schuler/Niebauer 40 -0.39 (1.03) 50 -0.25 (0.86) 6.2 % -0.14 [ -0.54, 0.26 ]
SCRIP 118 -0.99 (0.83) 127 -0.09 (0.63) 28.5 % -0.90 [ -1.09, -0.71 ]
Vermuelen 83 45 -0.43 (0.75) 46 -0.05 (0.88) 8.7 % -0.38 [ -0.72, -0.04 ]
WHO Helsinki 142 0.5 (0.94) 122 1.4 (1.07) 16.4 % -0.90 [ -1.14, -0.66 ]
Total (95% CI) 610 588 100.0 % -0.65 [ -0.75, -0.55 ]
Heterogeneity: Chi2 = 48.97, df = 8 (P<0.00001); I2 =84%
Test for overall effect: Z = 12.79 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Exercise plus other rehabilitation versus usual care, Outcome 6 LDL
Cholesterol.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 2 Exercise plus other rehabilitation versus usual care
Outcome: 6 LDL Cholesterol
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carlsson 98 CABG 31 -0.51 (1.12) 32 0.33 (0.75) 5.9 % -0.84 [ -1.31, -0.37 ]
Carlsson 98 AMI 75 -0.96 (0.83) 67 -0.01 (0.75) 19.4 % -0.95 [ -1.21, -0.69 ]
Engblom 85 -0.9 (0.96) 68 -0.75 (0.93) 14.5 % -0.15 [ -0.45, 0.15 ]
Lifestyle Heart 20 -0.73 (0.93) 15 -0.83 (0.65) 4.8 % 0.10 [ -0.42, 0.62 ]
Schuler/Niebauer 40 -0.24 (0.8) 50 0.03 (0.63) 14.3 % -0.27 [ -0.57, 0.03 ]
SCRIP 118 -0.95 (0.81) 127 -0.16 (0.59) 41.1 % -0.79 [ -0.97, -0.61 ]
Total (95% CI) 369 359 100.0 % -0.61 [ -0.73, -0.50 ]
Heterogeneity: Chi2 = 32.25, df = 5 (P<0.00001); I2 =84%
Test for overall effect: Z = 10.51 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Any rehabilitation intervention including exercise versus usual care, Outcome 1
Pooled mortality, non-fatal MI, CABG, PTCA.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 3 Any rehabilitation intervention including exercise versus usual care
Outcome: 1 Pooled mortality, non-fatal MI, CABG, PTCA
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Anderson 81 7/46 9/42 1.3 % 0.66 [ 0.23, 1.95 ]
Bell 99 8/102 8/102 1.4 % 1.00 [ 0.36, 2.77 ]
Bengtsson 83 12/81 10/90 1.8 % 1.39 [ 0.57, 3.40 ]
Bertie 92 1/57 4/53 0.5 % 0.27 [ 0.04, 1.59 ]
Bethell 90 25/113 26/116 3.8 % 0.98 [ 0.53, 1.83 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 0.4 % 0.98 [ 0.14, 7.05 ]
Carson 82 23/151 31/152 4.3 % 0.70 [ 0.39, 1.27 ]
Engblom 29/119 35/109 4.4 % 0.68 [ 0.38, 1.22 ]
Erdman 86 6/40 1/40 0.6 % 4.69 [ 1.00, 21.92 ]
Fletcher 94 3/41 4/47 0.6 % 0.85 [ 0.18, 3.97 ]
Fridlund 91 26/87 39/91 4.0 % 0.57 [ 0.31, 1.05 ]
Heller 93 46/213 54/237 7.5 % 0.93 [ 0.60, 1.46 ]
Holmback 94 3/34 2/35 0.5 % 1.58 [ 0.26, 9.61 ]
Kentala 72 10/152 12/146 2.0 % 0.79 [ 0.33, 1.87 ]
Lifestyle Heart 14/53 24/40 2.1 % 0.25 [ 0.11, 0.58 ]
NEHDP 30/323 35/328 5.6 % 0.86 [ 0.51, 1.43 ]
Oldridge 91 3/99 4/102 0.7 % 0.77 [ 0.17, 3.46 ]
PRECOR 6/60 11/61 1.4 % 0.52 [ 0.19, 1.44 ]
Schuler/Niebauer 20/56 25/57 2.6 % 0.71 [ 0.34, 1.51 ]
SCRIP 26/145 44/155 5.2 % 0.56 [ 0.33, 0.95 ]
Sivarajan 82 7/88 10/84 1.5 % 0.64 [ 0.24, 1.75 ]
Sivarajan 82 ex plus 10/86 10/84 1.7 % 0.97 [ 0.38, 2.47 ]
Speccia 96 17/125 21/131 3.1 % 0.83 [ 0.42, 1.64 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Stern 83 2/42 3/29 0.4 % 0.43 [ 0.07, 2.71 ]
Taylor 97 13/293 10/292 2.1 % 1.31 [ 0.57, 3.01 ]
Vecchio 81 0/25 3/25 0.3 % 0.12 [ 0.01, 1.25 ]
WHO Balatonfured 16/80 9/80 2.0 % 1.93 [ 0.83, 4.53 ]
WHO Brussels 25/85 24/81 3.3 % 0.99 [ 0.51, 1.92 ]
WHO Bucharest 16/65 23/64 2.6 % 0.59 [ 0.28, 1.24 ]
WHO Budapest 38/101 29/99 4.3 % 1.45 [ 0.81, 2.61 ]
WHO Dessau 4/29 7/25 0.9 % 0.42 [ 0.11, 1.58 ]
WHO Erfut 13/63 15/56 2.1 % 0.71 [ 0.31, 1.66 ]
WHO Ghent 19/84 12/84 2.4 % 1.73 [ 0.80, 3.77 ]
WHO Helsinki 41/188 56/187 6.9 % 0.65 [ 0.41, 1.04 ]
WHO Kaunas 19/66 17/49 2.3 % 0.76 [ 0.34, 1.68 ]
WHO Prague 15/59 20/53 2.3 % 0.57 [ 0.26, 1.26 ]
WHO Rome 8/34 6/29 1.1 % 1.18 [ 0.36, 3.83 ]
WHO Tel Aviv 14/63 8/51 1.7 % 1.52 [ 0.60, 3.85 ]
WHO Warsaw 6/39 8/40 1.1 % 0.73 [ 0.23, 2.31 ]
Wilhelmson 75 53/158 63/157 7.1 % 0.75 [ 0.48, 1.19 ]
Total (95% CI) 3863 3820 100.0 % 0.81 [ 0.72, 0.91 ]
Total events: 636 (Treatment), 734 (Control)
Heterogeneity: Chi2 = 43.66, df = 39 (P = 0.28); I2 =11%
Test for overall effect: Z = 3.44 (P = 0.00058)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Any rehabilitation intervention including exercise versus usual care, Outcome 2
Quality criteria - Random allocation: Outcome total mortality.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 3 Any rehabilitation intervention including exercise versus usual care
Outcome: 2 Quality criteria - Random allocation: Outcome total mortality
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Clear description - adequate randomisation
Anderson 81 4/46 3/42 1.1 % 1.23 [ 0.27, 5.74 ]
Bethell 90 16/113 12/116 4.2 % 1.42 [ 0.65, 3.14 ]
Carson 82 12/151 21/152 5.0 % 0.55 [ 0.27, 1.13 ]
Engblom 12/119 13/109 3.8 % 0.83 [ 0.36, 1.90 ]
Erdman 86 4/40 0/40 0.6 % 8.00 [ 1.08, 58.98 ]
Heller 93 6/213 3/237 1.5 % 2.20 [ 0.59, 8.25 ]
Holmback 94 1/34 1/35 0.3 % 1.03 [ 0.06, 16.81 ]
NEHDP 15/323 24/328 6.2 % 0.62 [ 0.33, 1.19 ]
Schuler/Niebauer 5/56 8/57 2.0 % 0.61 [ 0.19, 1.92 ]
SCRIP 3/145 3/155 1.0 % 1.07 [ 0.21, 5.38 ]
WHO Helsinki 41/188 56/187 12.2 % 0.65 [ 0.41, 1.04 ]
Wilhelmson 75 28/158 35/157 8.5 % 0.75 [ 0.43, 1.31 ]
Subtotal (95% CI) 1586 1615 46.3 % 0.79 [ 0.62, 1.00 ]
Total events: 147 (Treatment), 179 (Control)
Heterogeneity: Chi2 = 12.50, df = 11 (P = 0.33); I2 =12%
Test for overall effect: Z = 1.95 (P = 0.051)
2 Unclear description of method of randomisation
Bell 99 8/102 8/102 2.5 % 1.00 [ 0.36, 2.77 ]
Bengtsson 83 10/81 6/90 2.5 % 1.95 [ 0.70, 5.44 ]
Bertie 92 0/57 3/53 0.5 % 0.12 [ 0.01, 1.19 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 0.7 % 0.98 [ 0.14, 7.05 ]
Fletcher 94 3/41 4/47 1.1 % 0.85 [ 0.18, 3.97 ]
Lifestyle Heart 2/53 1/40 0.5 % 1.50 [ 0.15, 15.10 ]
Oldridge 91 3/99 4/102 1.1 % 0.77 [ 0.17, 3.46 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
PRECOR 0/60 4/61 0.7 % 0.13 [ 0.02, 0.95 ]
Sivarajan 82 3/88 2/84 0.8 % 1.44 [ 0.24, 8.47 ]
Sivarajan 82 ex plus 3/86 2/84 0.8 % 1.47 [ 0.25, 8.67 ]
Speccia 96 5/125 13/131 2.8 % 0.41 [ 0.16, 1.06 ]
Stern 83 0/42 1/29 0.2 % 0.09 [ 0.00, 4.66 ]
Taylor 97 13/293 10/292 3.7 % 1.31 [ 0.57, 3.01 ]
Vecchio 81 0/25 2/25 0.3 % 0.13 [ 0.01, 2.14 ]
WHO Balatonfured 9/80 9/80 2.7 % 1.00 [ 0.38, 2.66 ]
WHO Brussels 14/85 22/81 4.8 % 0.53 [ 0.26, 1.12 ]
WHO Bucharest 8/65 10/64 2.6 % 0.76 [ 0.28, 2.05 ]
WHO Budapest 21/101 17/99 5.2 % 1.26 [ 0.62, 2.56 ]
WHO Dessau 2/29 4/25 0.9 % 0.40 [ 0.07, 2.18 ]
WHO Erfut 11/63 12/56 3.1 % 0.78 [ 0.31, 1.93 ]
WHO Ghent 15/84 3/84 2.7 % 4.41 [ 1.66, 11.70 ]
WHO Kaunas 14/66 12/49 3.4 % 0.83 [ 0.34, 2.00 ]
WHO Prague 9/59 11/53 2.8 % 0.69 [ 0.26, 1.81 ]
WHO Rome 7/34 6/29 1.8 % 0.99 [ 0.30, 3.35 ]
WHO Tel Aviv 5/63 4/51 1.4 % 1.01 [ 0.26, 3.96 ]
WHO Warsaw 1/39 7/40 1.2 % 0.20 [ 0.05, 0.85 ]
Subtotal (95% CI) 2038 1968 50.9 % 0.88 [ 0.70, 1.10 ]
Total events: 168 (Treatment), 179 (Control)
Heterogeneity: Chi2 = 34.84, df = 25 (P = 0.09); I2 =28%
Test for overall effect: Z = 1.16 (P = 0.25)
3 Clear description - inadequate randomisation
Fridlund 91 1/87 3/91 0.7 % 0.38 [ 0.05, 2.73 ]
Kentala 72 5/152 8/146 2.1 % 0.59 [ 0.20, 1.80 ]
Subtotal (95% CI) 239 237 2.8 % 0.53 [ 0.20, 1.40 ]
Total events: 6 (Treatment), 11 (Control)
Heterogeneity: Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 3863 3820 100.0 % 0.82 [ 0.70, 0.97 ]
Total events: 321 (Treatment), 369 (Control)
Heterogeneity: Chi2 = 48.67, df = 39 (P = 0.14); I2 =20%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Chi2 = 1.18, df = 2 (P = 0.56), I2 =0.0%
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Analysis 3.3. Comparison 3 Any rehabilitation intervention including exercise versus usual care, Outcome 3
Quality criteria - Loss to follow up: Outcome total mortality.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 3 Any rehabilitation intervention including exercise versus usual care
Outcome: 3 Quality criteria - Loss to follow up: Outcome total mortality
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Less than 20% loss to follow up
Anderson 81 4/46 3/42 1.1 % 1.23 [ 0.27, 5.74 ]
Bell 99 8/102 8/102 2.5 % 1.00 [ 0.36, 2.77 ]
Bethell 90 16/113 12/116 4.2 % 1.42 [ 0.65, 3.14 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 0.7 % 0.98 [ 0.14, 7.05 ]
Engblom 12/119 13/109 3.8 % 0.83 [ 0.36, 1.90 ]
Heller 93 6/213 3/237 1.5 % 2.20 [ 0.59, 8.25 ]
Holmback 94 1/34 1/35 0.3 % 1.03 [ 0.06, 16.81 ]
Lifestyle Heart 2/53 1/40 0.5 % 1.50 [ 0.15, 15.10 ]
NEHDP 15/323 24/328 6.2 % 0.62 [ 0.33, 1.19 ]
Oldridge 91 3/99 4/102 1.1 % 0.77 [ 0.17, 3.46 ]
PRECOR 0/60 4/61 0.7 % 0.13 [ 0.02, 0.95 ]
SCRIP 3/145 3/155 1.0 % 1.07 [ 0.21, 5.38 ]
Speccia 96 5/125 13/131 2.8 % 0.41 [ 0.16, 1.06 ]
Stern 83 0/42 1/29 0.2 % 0.09 [ 0.00, 4.66 ]
WHO Balatonfured 9/80 9/80 2.7 % 1.00 [ 0.38, 2.66 ]
WHO Brussels 14/85 22/81 4.8 % 0.53 [ 0.26, 1.12 ]
WHO Budapest 21/101 17/99 5.2 % 1.26 [ 0.62, 2.56 ]
WHO Dessau 2/29 4/25 0.9 % 0.40 [ 0.07, 2.18 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
WHO Erfut 11/63 12/56 3.1 % 0.78 [ 0.31, 1.93 ]
WHO Ghent 15/84 3/84 2.7 % 4.41 [ 1.66, 11.70 ]
WHO Helsinki 41/188 56/187 12.2 % 0.65 [ 0.41, 1.04 ]
WHO Kaunas 14/66 12/49 3.4 % 0.83 [ 0.34, 2.00 ]
WHO Prague 9/59 11/53 2.8 % 0.69 [ 0.26, 1.81 ]
WHO Rome 7/34 6/29 1.8 % 0.99 [ 0.30, 3.35 ]
WHO Tel Aviv 5/63 4/51 1.4 % 1.01 [ 0.26, 3.96 ]
Wilhelmson 75 28/158 35/157 8.5 % 0.75 [ 0.43, 1.31 ]
Subtotal (95% CI) 2602 2555 76.0 % 0.84 [ 0.69, 1.00 ]
Total events: 253 (Treatment), 283 (Control)
Heterogeneity: Chi2 = 28.48, df = 25 (P = 0.29); I2 =12%
Test for overall effect: Z = 1.91 (P = 0.056)
2 Greater than 20% loss to follow up
Bengtsson 83 10/81 6/90 2.5 % 1.95 [ 0.70, 5.44 ]
Bertie 92 0/57 3/53 0.5 % 0.12 [ 0.01, 1.19 ]
Carson 82 12/151 21/152 5.0 % 0.55 [ 0.27, 1.13 ]
Erdman 86 4/40 0/40 0.6 % 8.00 [ 1.08, 58.98 ]
Fletcher 94 3/41 4/47 1.1 % 0.85 [ 0.18, 3.97 ]
Fridlund 91 1/87 3/91 0.7 % 0.38 [ 0.05, 2.73 ]
Kentala 72 5/152 8/146 2.1 % 0.59 [ 0.20, 1.80 ]
Schuler/Niebauer 5/56 8/57 2.0 % 0.61 [ 0.19, 1.92 ]
Sivarajan 82 3/88 2/84 0.8 % 1.44 [ 0.24, 8.47 ]
Sivarajan 82 ex plus 3/86 2/84 0.8 % 1.47 [ 0.25, 8.67 ]
Taylor 97 13/293 10/292 3.7 % 1.31 [ 0.57, 3.01 ]
Vecchio 81 0/25 2/25 0.3 % 0.13 [ 0.01, 2.14 ]
WHO Bucharest 8/65 10/64 2.6 % 0.76 [ 0.28, 2.05 ]
WHO Warsaw 1/39 7/40 1.2 % 0.20 [ 0.05, 0.85 ]
Subtotal (95% CI) 1261 1265 24.0 % 0.79 [ 0.57, 1.09 ]
Total events: 68 (Treatment), 86 (Control)
Heterogeneity: Chi2 = 20.10, df = 13 (P = 0.09); I2 =35%
Test for overall effect: Z = 1.43 (P = 0.15)
Total (95% CI) 3863 3820 100.0 % 0.82 [ 0.70, 0.97 ]
Total events: 321 (Treatment), 369 (Control)
Heterogeneity: Chi2 = 48.67, df = 39 (P = 0.14); I2 =20%
Test for overall effect: Z = 2.36 (P = 0.018)
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.76), I2 =0.0%
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Analysis 3.4. Comparison 3 Any rehabilitation intervention including exercise versus usual care, Outcome 4
Quality criteria - Blind assessment of outcomes.
Review: Exercise-based rehabilitation for coronary heart disease
Comparison: 3 Any rehabilitation intervention including exercise versus usual care
Outcome: 4 Quality criteria - Blind assessment of outcomes
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Yes - clearly described
Bell 99 8/102 8/102 2.5 % 1.00 [ 0.36, 2.77 ]
Carson 82 12/151 21/152 5.0 % 0.55 [ 0.27, 1.13 ]
Heller 93 6/213 3/237 1.5 % 2.20 [ 0.59, 8.25 ]
Holmback 94 1/34 1/35 0.3 % 1.03 [ 0.06, 16.81 ]
Lifestyle Heart 2/53 1/40 0.5 % 1.50 [ 0.15, 15.10 ]
NEHDP 15/323 24/328 6.2 % 0.62 [ 0.33, 1.19 ]
Schuler/Niebauer 5/56 8/57 2.0 % 0.61 [ 0.19, 1.92 ]
Sivarajan 82 3/88 2/84 0.8 % 1.44 [ 0.24, 8.47 ]
Sivarajan 82 ex plus 3/86 2/84 0.8 % 1.47 [ 0.25, 8.67 ]
Subtotal (95% CI) 1106 1119 19.6 % 0.78 [ 0.54, 1.12 ]
Total events: 55 (Treatment), 70 (Control)
Heterogeneity: Chi2 = 5.46, df = 8 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.35 (P = 0.18)
2 Unclear
Anderson 81 4/46 3/42 1.1 % 1.23 [ 0.27, 5.74 ]
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(. . . Continued)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Bengtsson 83 10/81 6/90 2.5 % 1.95 [ 0.70, 5.44 ]
Bertie 92 0/57 3/53 0.5 % 0.12 [ 0.01, 1.19 ]
Bethell 90 16/113 12/116 4.2 % 1.42 [ 0.65, 3.14 ]
Carlsson 98 CABG 0/33 0/34 Not estimable
Carlsson 98 AMI 2/85 2/83 0.7 % 0.98 [ 0.14, 7.05 ]
Engblom 12/119 13/109 3.8 % 0.83 [ 0.36, 1.90 ]
Erdman 86 4/40 0/40 0.6 % 8.00 [ 1.08, 58.98 ]
Fletcher 94 3/41 4/47 1.1 % 0.85 [ 0.18, 3.97 ]
Fridlund 91 1/87 3/91 0.7 % 0.38 [ 0.05, 2.73 ]
Kentala 72 5/152 8/146 2.1 % 0.59 [ 0.20, 1.80 ]
Oldridge 91 3/99 4/102 1.1 % 0.77 [ 0.17, 3.46 ]
PRECOR 0/60 4/61 0.7 % 0.13 [ 0.02, 0.95 ]
SCRIP 3/145 3/155 1.0 % 1.07 [ 0.21, 5.38 ]
Speccia 96 0/42 1/29 0.2 % 0.09 [ 0.00, 4.66 ]
Stern 83 5/125 13/131 2.8 % 0.41 [ 0.16, 1.06 ]
Taylor 97 13/293 10/292 3.7 % 1.31 [ 0.57, 3.01 ]
Vecchio 81 0/25 2/25 0.3 % 0.13 [ 0.01, 2.14 ]
WHO Balatonfured 9/80 9/80 2.7 % 1.00 [ 0.38, 2.66 ]
WHO Brussels 14/85 22/81 4.8 % 0.53 [ 0.26, 1.12 ]
WHO Bucharest 8/65 10/64 2.6 % 0.76 [ 0.28, 2.05 ]
WHO Budapest 21/101 17/99 5.2 % 1.26 [ 0.62, 2.56 ]
WHO Dessau 2/29 4/25 0.9 % 0.40 [ 0.07, 2.18 ]
WHO Erfut 11/63 12/56 3.1 % 0.78 [ 0.31, 1.93 ]
WHO Ghent 15/84 3/84 2.7 % 4.41 [ 1.66, 11.70 ]
WHO Helsinki 41/188 56/187 12.2 % 0.65 [ 0.41, 1.04 ]
WHO Kaunas 14/66 12/49 3.4 % 0.83 [ 0.34, 2.00 ]
WHO Prague 9/59 11/53 2.8 % 0.69 [ 0.26, 1.81 ]
WHO Rome 7/34 6/29 1.8 % 0.99 [ 0.30, 3.35 ]
WHO Tel Aviv 5/63 4/51 1.4 % 1.01 [ 0.26, 3.96 ]
WHO Warsaw 1/39 7/40 1.2 % 0.20 [ 0.05, 0.85 ]
Wilhelmson 75 28/158 35/157 8.5 % 0.75 [ 0.43, 1.31 ]
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Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Subtotal (95% CI) 2757 2701 80.4 % 0.83 [ 0.70, 1.00 ]
Total events: 266 (Treatment), 299 (Control)
Heterogeneity: Chi2 = 43.09, df = 30 (P = 0.06); I2 =30%
Test for overall effect: Z = 1.97 (P = 0.049)
Total (95% CI) 3863 3820 100.0 % 0.82 [ 0.70, 0.97 ]
Total events: 321 (Treatment), 369 (Control)
Heterogeneity: Chi2 = 48.67, df = 39 (P = 0.14); I2 =20%
Test for overall effect: Z = 2.36 (P = 0.018)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
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